Upland Software, Inc 10-Q for FY2026 Q3
Upland Software, Inc. (UPLD)
10-Q
2026-11-04
For: 2026-09-30
View Original
Added on
November 04, 2026
About this 10-Q
Upland Software, Inc filed this 10-Q on November 4, 2026, covering the quarter ended September 30, 2026 (FY2026 Q3).
Headline figures
Quarter ended September 30, 2026, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $47.53M
- down 5.9% from $50.53M a year earlier
- Net loss
- $451K
- compared with a net loss of $1.12M a year earlier
- Diluted EPS
- -$0.67
- compared with -$0.90 a year earlier
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
For the quarterly period ended September 30, 2026
OR
For the transition period from to
Commission file number 001-36720

(Exact name of registrant as specified in its charter)
| (State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) | ||||
(Address, including zip code, of registrant’s principal executive offices)
(512 ) 960-1010
(Registrant’s telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol | Name of each exchange on which registered | ||||||||||||
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company”, and "emerging growth company" in Rule 12b-2 of the Exchange Act.
| Large accelerated filer | ☐ | Accelerated filer | ☐ | |||||||||||
| x | Smaller reporting company | |||||||||||||
| Emerging growth company | ||||||||||||||
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
Indicate the number of shares outstanding of each of the issuer's classes of common stock, as of the latest practicable date.
As of November 2, 2026, 2,838,697 shares of the registrant’s Common Stock were outstanding.
Upland Software, Inc.
Table of Contents
| Page | ||||||||
| Condensed Consolidated Balance Sheets as of September 30, 2026 and December 31, 2025 | ||||||||
| Condensed Consolidated Statements of Operations for the Three and Nine Months Ended September 30, 2026 and September 30, 2025 | ||||||||
| Condensed Consolidated Statements of Comprehensive Income (Loss) for the Three and Nine Months Ended September 30, 2026 and September 30, 2025 | ||||||||
| Condensed Consolidated Statements of Stockholders' Deficit for the Three and Nine Months Ended September 30, 2026 and September 30, 2025 | ||||||||
| Condensed Consolidated Statements of Cash Flows for the Nine Months Ended September 30, 2026 and September 30, 2025 | ||||||||
Upland Software, Inc.
Condensed Consolidated Balance Sheets
(in thousands, except for share and per share amounts)
Item 1. Financial Statements
| September 30, 2026 | December 31, 2025 | |||||||||||||||||||||||||
| (unaudited) | ||||||||||||||||||||||||||
| ASSETS | ||||||||||||||||||||||||||
| Current assets: | ||||||||||||||||||||||||||
| Cash and cash equivalents | $ | $ | ||||||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||||||||
Accounts receivable (net of allowance of $ | ||||||||||||||||||||||||||
| Deferred commissions, current | ||||||||||||||||||||||||||
| Unbilled receivables | ||||||||||||||||||||||||||
| Income tax receivable, current | ||||||||||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||||||||||
| Total current assets | ||||||||||||||||||||||||||
| Tax credits receivable | ||||||||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||||||||
| Operating lease right-of-use asset | ||||||||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||||||||
| Goodwill | ||||||||||||||||||||||||||
| Deferred commissions, noncurrent | ||||||||||||||||||||||||||
| Interest rate derivatives | ||||||||||||||||||||||||||
| Other assets | ||||||||||||||||||||||||||
| Total assets | $ | $ | ||||||||||||||||||||||||
| LIABILITIES, CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' DEFICIT | ||||||||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||||||||
| Accounts payable | $ | $ | ||||||||||||||||||||||||
| Accrued compensation | ||||||||||||||||||||||||||
| Accrued expenses and other current liabilities | ||||||||||||||||||||||||||
| Deferred revenue | ||||||||||||||||||||||||||
| Operating lease liabilities, current | ||||||||||||||||||||||||||
Current maturities of notes payable (includes unamortized discount of $ | ||||||||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||||||||
Notes payable, less current maturities (includes unamortized discount of $ | ||||||||||||||||||||||||||
| Deferred revenue, noncurrent | ||||||||||||||||||||||||||
| Operating lease liabilities, noncurrent | ||||||||||||||||||||||||||
| Noncurrent deferred tax liability, net | ||||||||||||||||||||||||||
| Other long-term liabilities | ||||||||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||||||||
| Mezzanine equity: | ||||||||||||||||||||||||||
Series A Convertible Preferred stock, $ | ||||||||||||||||||||||||||
| Stockholders’ deficit: | ||||||||||||||||||||||||||
Common stock, $ | ||||||||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||||||||
| Accumulated other comprehensive loss | ( | ( | ||||||||||||||||||||||||
| Accumulated deficit | ( | ( | ||||||||||||||||||||||||
| Total stockholders’ deficit | ( | ( | ||||||||||||||||||||||||
| Total liabilities, convertible preferred stock and stockholders’ deficit | $ | $ | ||||||||||||||||||||||||
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
1
Upland Software, Inc.
Condensed Consolidated Statements of Operations
(unaudited)
(in thousands, except for share and per share amounts)
| Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||||||||||||
| 2026 | 2025 | 2026 | 2025 | |||||||||||||||||||||||
| Revenue: | ||||||||||||||||||||||||||
| Subscription and support | $ | $ | $ | $ | ||||||||||||||||||||||
| Perpetual license | ||||||||||||||||||||||||||
| Total product revenue | ||||||||||||||||||||||||||
| Professional services | ||||||||||||||||||||||||||
| Total revenue | ||||||||||||||||||||||||||
| Cost of revenue: | ||||||||||||||||||||||||||
| Subscription and support | ||||||||||||||||||||||||||
| Professional services and other | ||||||||||||||||||||||||||
| Total cost of revenue | ||||||||||||||||||||||||||
| Gross profit | ||||||||||||||||||||||||||
| Operating expenses: | ||||||||||||||||||||||||||
| Sales and marketing | ||||||||||||||||||||||||||
| Research and development | ||||||||||||||||||||||||||
| General and administrative | ||||||||||||||||||||||||||
| Depreciation and amortization | ||||||||||||||||||||||||||
| Divestiture-related expenses | ||||||||||||||||||||||||||
| Impairment of goodwill and other intangibles | ||||||||||||||||||||||||||
| Total operating expenses | ||||||||||||||||||||||||||
| Income (loss) from operations | ( | ( | ||||||||||||||||||||||||
| Other income (expense): | ||||||||||||||||||||||||||
| Interest expense, net | ( | ( | ( | ( | ||||||||||||||||||||||
| Loss on divestitures of businesses | ( | ( | ||||||||||||||||||||||||
| Loss on debt extinguishment | ( | ( | ||||||||||||||||||||||||
| Other income (expense), net | ( | ( | ||||||||||||||||||||||||
| Total other expense, net | ( | ( | ( | ( | ||||||||||||||||||||||
| Income (loss) before benefit from (provision for) income taxes | ( | ( | ( | |||||||||||||||||||||||
| Benefit from (provision for) income taxes | ( | ( | ||||||||||||||||||||||||
| Net loss | $ | ( | $ | ( | $ | ( | $ | ( | ||||||||||||||||||
| Preferred stock dividends | ( | ( | ( | ( | ||||||||||||||||||||||
| Net loss attributable to common stockholders | $ | ( | $ | ( | $ | ( | $ | ( | ||||||||||||||||||
| Net loss per common share: | ||||||||||||||||||||||||||
| Net loss per common share, basic and diluted | $ | ( | $ | ( | $ | ( | $ | ( | ||||||||||||||||||
| Weighted-average common shares outstanding, basic and diluted | ||||||||||||||||||||||||||
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
2
Upland Software, Inc.
Condensed Consolidated Statements of Comprehensive Income (Loss)
(unaudited)
(in thousands)
| Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||||||||||||
| 2026 | 2025 | 2026 | 2025 | |||||||||||||||||||||||
| Net loss | $ | ( | $ | ( | $ | ( | $ | ( | ||||||||||||||||||
| Other comprehensive income (loss): | ||||||||||||||||||||||||||
| Unrealized foreign currency translation adjustment | ( | ( | ||||||||||||||||||||||||
| Realized foreign currency gain (loss) | ||||||||||||||||||||||||||
| Unrealized translation gain (loss) on foreign currency denominated intercompany loans, net of taxes | ( | |||||||||||||||||||||||||
| Interest rate swaps, net of reclassifications into earnings | ( | ( | ( | ( | ||||||||||||||||||||||
| Other comprehensive income (loss): | $ | ( | $ | ( | $ | ( | $ | |||||||||||||||||||
| Comprehensive loss | $ | ( | $ | ( | $ | ( | $ | ( | ||||||||||||||||||
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
3
Upland Software, Inc.
Condensed Consolidated Statements of Stockholders’ Deficit
(unaudited)
(in thousands, except share amounts)
| Three Months Ended September 30, 2026 | |||||||||||||||||||||||||||||||||||||||||||||||
| Preferred Stock | Common Stock | Additional Paid-In Capital | Accumulated Other Comprehensive Income (Loss) | Accumulated Deficit | Total Stockholders’ Equity (Deficit) | ||||||||||||||||||||||||||||||||||||||||||
| Shares | Amount | Shares | Amount | ||||||||||||||||||||||||||||||||||||||||||||
| Balance at June 30, 2026 | $ | $ | $ | $ | ( | $ | ( | $ | ( | ||||||||||||||||||||||||||||||||||||||
| Dividends accrued - Convertible Preferred Stock | — | — | — | ( | — | — | ( | ||||||||||||||||||||||||||||||||||||||||
| Issuance of stock under Company plans, net of shares withheld for tax | — | — | — | ( | — | — | ( | ||||||||||||||||||||||||||||||||||||||||
| Stock repurchases and retirements | — | — | ( | — | ( | — | — | ( | |||||||||||||||||||||||||||||||||||||||
| Stock-based compensation | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||
| Unrealized foreign currency translation adjustment | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||
| Unrealized translation gain (loss) on intercompany loans with foreign subsidiaries, net of taxes | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||
| Interest rate swaps | — | — | — | — | — | ( | — | ( | |||||||||||||||||||||||||||||||||||||||
| Net loss | — | — | — | — | — | — | ( | ( | |||||||||||||||||||||||||||||||||||||||
| Balance at September 30, 2026 | $ | $ | $ | $ | ( | $ | ( | $ | ( | ||||||||||||||||||||||||||||||||||||||
| Three Months Ended September 30, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||
| Preferred Stock | Common Stock | Additional Paid-In Capital | Accumulated Other Comprehensive Income (Loss) | Accumulated Deficit | Total Stockholders’ Equity (Deficit) | ||||||||||||||||||||||||||||||||||||||||||
| Shares | Amount | Shares | Amount | ||||||||||||||||||||||||||||||||||||||||||||
| Balance at June 30, 2025 | $ | $ | $ | $ | ( | $ | ( | $ | ( | ||||||||||||||||||||||||||||||||||||||
| Dividends accrued - Convertible Preferred Stock | — | — | — | ( | — | — | ( | ||||||||||||||||||||||||||||||||||||||||
| Issuance of stock under Company plans, net of shares withheld for tax | — | — | — | ( | — | — | ( | ||||||||||||||||||||||||||||||||||||||||
| Stock repurchases and retirements | — | — | ( | — | ( | — | — | ( | |||||||||||||||||||||||||||||||||||||||
| Stock-based compensation | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||
| Unrealized foreign currency translation adjustment | — | — | — | — | — | ( | — | ( | |||||||||||||||||||||||||||||||||||||||
| Unrealized translation gain (loss) on intercompany loans with foreign subsidiaries, net of taxes | — | — | — | — | — | ( | — | ( | |||||||||||||||||||||||||||||||||||||||
| Interest rate swaps | — | — | — | — | — | ( | — | ( | |||||||||||||||||||||||||||||||||||||||
| Net loss | — | — | — | — | — | — | ( | ( | |||||||||||||||||||||||||||||||||||||||
| Balance at September 30, 2025 | $ | $ | $ | $ | ( | $ | ( | $ | ( | ||||||||||||||||||||||||||||||||||||||
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
4
Upland Software, Inc.
Condensed Consolidated Statements of Stockholders’ Deficit - continued
(unaudited)
(in thousands, except share amounts)
| Nine Months Ended September 30, 2026 | |||||||||||||||||||||||||||||||||||||||||||||||
| Preferred Stock | Common Stock | Additional Paid-In Capital | Accumulated Other Comprehensive Income (Loss) | Accumulated Deficit | Total Stockholders’ Equity (Deficit) | ||||||||||||||||||||||||||||||||||||||||||
| Shares | Amount | Shares | Amount | ||||||||||||||||||||||||||||||||||||||||||||
| Balance at December 31, 2025 | $ | $ | $ | $ | ( | $ | ( | $ | ( | ||||||||||||||||||||||||||||||||||||||
| Dividends accrued - Convertible Preferred Stock | — | — | — | ( | — | — | ( | ||||||||||||||||||||||||||||||||||||||||
| Issuance of stock under Company plans, net of shares withheld for tax | — | — | — | ( | — | — | ( | ||||||||||||||||||||||||||||||||||||||||
| Fractional share adjustment due to reverse stock split | — | — | ( | — | ( | — | — | ( | |||||||||||||||||||||||||||||||||||||||
| Stock repurchases and retirements | — | — | ( | — | ( | — | — | ( | |||||||||||||||||||||||||||||||||||||||
| Stock-based compensation | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||
| Unrealized foreign currency translation adjustment | — | — | — | — | — | ( | — | ( | |||||||||||||||||||||||||||||||||||||||
| Unrealized translation gain (loss) on intercompany loans with foreign subsidiaries, net of taxes | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||
| Interest rate swaps | — | — | — | — | — | ( | — | ( | |||||||||||||||||||||||||||||||||||||||
| Net loss | — | — | — | — | — | — | ( | ( | |||||||||||||||||||||||||||||||||||||||
| Balance at September 30, 2026 | $ | $ | $ | $ | ( | $ | ( | $ | ( | ||||||||||||||||||||||||||||||||||||||
| Nine Months Ended September 30, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||
| Preferred Stock | Common Stock | Additional Paid-In Capital | Accumulated Other Comprehensive Income (Loss) | Accumulated Deficit | Total Stockholders’ Equity (Deficit) | ||||||||||||||||||||||||||||||||||||||||||
| Shares | Amount | Shares | Amount | ||||||||||||||||||||||||||||||||||||||||||||
| Balance at December 31, 2024 | $ | $ | $ | $ | ( | $ | ( | $ | ( | ||||||||||||||||||||||||||||||||||||||
| Dividends accrued - Convertible Preferred Stock | — | — | — | ( | — | — | ( | ||||||||||||||||||||||||||||||||||||||||
| Issuance of stock under Company plans, net of shares withheld for tax | — | — | — | ( | — | — | ( | ||||||||||||||||||||||||||||||||||||||||
| Stock repurchases and retirements | — | — | ( | — | ( | — | — | ( | |||||||||||||||||||||||||||||||||||||||
| Stock-based compensation | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||
| Realized translation loss on divestiture of businesses | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||
| Unrealized foreign currency translation adjustment | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||
| Unrealized translation gain (loss) on intercompany loans with foreign subsidiaries, net of taxes | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||
| Interest rate swaps | — | — | — | — | — | ( | — | ( | |||||||||||||||||||||||||||||||||||||||
| Net loss | — | — | — | — | — | — | ( | ( | |||||||||||||||||||||||||||||||||||||||
| Balance at September 30, 2025 | $ | $ | $ | $ | ( | $ | ( | $ | ( | ||||||||||||||||||||||||||||||||||||||
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
5
| Upland Software, Inc. | ||||||||||||||
| Condensed Consolidated Statements of Cash Flows | ||||||||||||||
| (unaudited) | ||||||||||||||
| (in thousands) | ||||||||||||||
| Nine Months Ended September 30, | ||||||||||||||
| 2026 | 2025 | |||||||||||||
| Operating activities | ||||||||||||||
| Net loss | $ | ( | $ | ( | ||||||||||
| Adjustments to reconcile net loss to net cash provided by operating activities: | ||||||||||||||
| Depreciation and amortization | ||||||||||||||
| Deferred income taxes | ( | ( | ||||||||||||
| Amortization of deferred costs | ||||||||||||||
| Foreign currency re-measurement loss | ||||||||||||||
| Non-cash interest, net and other income, net | ( | ( | ||||||||||||
| Non-cash stock-based compensation expense | ||||||||||||||
| Non-cash loss on impairment of goodwill and other intangibles | ||||||||||||||
| Non-cash loss on divestitures of businesses | ||||||||||||||
| Non-cash loss on retirement of fixed assets | ||||||||||||||
| Non-cash loss on debt extinguishment | ||||||||||||||
| Changes in operating assets and liabilities: | ||||||||||||||
| Accounts receivable | ||||||||||||||
| Prepaid expenses and other current assets | ( | ( | ||||||||||||
| Other assets | ( | |||||||||||||
| Accounts payable | ( | |||||||||||||
| Accrued expenses and other liabilities | ( | |||||||||||||
| Deferred revenue | ( | ( | ||||||||||||
| Net cash provided by operating activities | ||||||||||||||
| Investing activities | ||||||||||||||
| Purchase of property and equipment | ( | ( | ||||||||||||
| Collections on note receivable | ||||||||||||||
Proceeds from the divestitures of businesses, net of cash transferred | ||||||||||||||
| Net cash provided by investing activities | ||||||||||||||
| Financing activities | ||||||||||||||
| Proceeds from notes payable, net of debt discount | ||||||||||||||
| Payments on notes payable | ( | ( | ||||||||||||
| Payments of debt issuance costs | ( | ( | ||||||||||||
| Stock repurchases and retirements | ( | ( | ||||||||||||
| Taxes paid related to net share settlement of equity awards | ( | ( | ||||||||||||
| Net cash used in financing activities | ( | ( | ||||||||||||
| Effect of exchange rate fluctuations on cash, cash equivalents and restricted cash | ( | |||||||||||||
| Change in cash, cash equivalents and restricted cash | ( | ( | ||||||||||||
| Cash, cash equivalents and restricted cash, beginning of period | ||||||||||||||
| Cash, cash equivalents and restricted cash, end of period | $ | $ | ||||||||||||
| Supplemental disclosures of cash flow information: | ||||||||||||||
| Cash paid for interest, net of interest rate derivatives | $ | $ | ||||||||||||
| Cash paid for taxes, net of refunds | $ | $ | ||||||||||||
| Non-cash investing and financing activities: | ||||||||||||||
| Note receivable from divestiture of businesses, net of discount | $ | $ | ||||||||||||
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
6
Upland Software, Inc.
Notes to Unaudited Condensed Consolidated Financial Statements
(unaudited)
1. Organization and Nature of Operations
Upland Software, Inc., together with its wholly owned subsidiaries (“Upland,” “we,” “us,” “our,” or the “Company”), a Delaware corporation headquartered in Austin, Texas, provides an intelligence layer that unifies and contextualizes enterprise knowledge, content, and data, turning isolated information into actionable outcomes for every human and agent. More than 1,100 enterprise customers rely on Upland's deep domain expertise to drive measurable, value-add outcomes, unlocking the full potential of AI as their organizations evolve. The Company's customers operate in a wide variety of industries, including financial services, consulting services, technology, manufacturing, media, telecommunications, government, insurance, non-profit, healthcare, life sciences, retail, and hospitality.
2. Basis of Presentation and Summary of Significant Accounting Policies
Basis of Presentation
These condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States (“GAAP”). The condensed consolidated financial statements include the accounts of Upland Software, Inc. and its wholly owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation. No material changes have been made to the Company’s significant accounting policies disclosed in Note 2, Basis of Presentation and Summary of Significant Accounting Policies, in the Company’s Annual Report on Form 10-K.
The accompanying unaudited interim condensed consolidated financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”) for interim financial reporting. In the opinion of management of the Company, the unaudited interim condensed consolidated financial statements have been prepared on the same basis as the audited consolidated financial statements, in all material respects, and include all adjustments of a normal recurring nature necessary for a fair presentation. The results of operations for the nine months ended September 30, 2026 are not necessarily indicative of the results to be expected for the year ending December 31, 2026 or for any other period.
The financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s 2025 Annual Report on Form 10-K.
Use of Estimates
The preparation of the accompanying condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, and the reported amounts of revenues and expenses. Significant items subject to such estimates include those related to revenue recognition, deferred commissions, allowance for credit losses, stock-based compensation, impairment of goodwill, intangibles and long-lived assets, the useful lives of intangible assets and property and equipment, the fair value of the Company’s interest rate derivatives and income taxes. In accordance with GAAP, management bases its estimates on historical experience and on various other assumptions that management believes are reasonable under the circumstances. Management regularly evaluates its estimates and assumptions using historical experience and other factors; however, actual results could differ from those estimates.
Restricted Cash
| September 30, 2026 | December 31, 2025 | ||||||||||||||||
| Cash and cash equivalents | $ | $ | |||||||||||||||
| Restricted cash | |||||||||||||||||
| Total cash, cash equivalents and restricted cash | $ | $ | |||||||||||||||
7
Concentrations of Credit Risk and Significant Customers
Financial instruments that potentially subject the Company to credit risk consist of cash and cash equivalents, accounts receivable, and other assets. The Company’s cash and cash equivalents are placed with high quality financial institutions, which, at times, may exceed federally insured limits. The Company has not experienced any losses in these accounts, and the Company does not believe it is exposed to any significant credit risk related to cash and cash equivalents. The Company provides credit, in the normal course of business, to a number of its customers and generally does not require collateral. To manage accounts receivable credit risk, the Company performs periodic credit evaluations of its customers and maintains current expected credit losses which considers such factors as historical loss information, geographic location of customers, current market conditions, and reasonable and supportable forecasts.
No individual customer represented more than 10% of total revenues for the three and nine months ended September 30, 2026 or September 30, 2025 and no individual customer represented more than 10% of accounts receivable as of September 30, 2026 or December 31, 2025.
Recent Accounting Pronouncements
Recently issued accounting pronouncements - Adopted
In July 2025, the Financial Accounting Standards Board (“FASB”) issued ASU 2025-05 Measurement of Credit Losses for Accounts Receivable and Contract Assets related to credit losses for accounts receivable and contract assets. ASU 2025-05 provides a practical expedient permitting an entity to assume that conditions at the balance sheet date remain unchanged over the life of the asset when estimating expected credit losses for current accounts receivable and current contract assets. This ASU is effective for annual periods beginning after December 15, 2025, including interim periods within those fiscal years, with early adoption permitted. Entities that elect the practical expedient and, if applicable, make the accounting policy election are required to apply the amendments prospectively. The Company adopted the standard on January 1, 2026, on a prospective basis and elected to apply the practical expedient to its estimate of expected credit losses for current accounts receivable and current contract assets. The adoption did not have a material impact on the Company’s consolidated financial statements.
In November 2024, the FASB issued ASU 2024-04, Debt-Debt with Conversions and Other Options. ASU 2024-04 is intended to clarify requirements for determining whether certain settlements of convertible debt instruments, including convertible debt instruments with cash conversion features or convertible debt instruments that are not currently convertible, should be accounted for as an induced conversion. This ASU is effective for all entities for annual reporting periods beginning after December 15, 2025, and interim reporting periods within those annual reporting periods, with early adoption permitted. The Company adopted this guidance effective January 1, 2026. The adoption did not have a material impact on the Company’s consolidated financial statements.
Recently issued accounting pronouncements - Not Adopted
In September 2025, the FASB issued accounting standards update (“ASU”) 2025-07 Derivatives and Hedging (Topic 815) and Revenue from Contracts with Customers (Topic 606): Derivatives Scope Refinements and Scope Clarification for Share-Based Noncash Consideration from a Customer in a Revenue Contract. ASU 2025-07 expands the scope exception for certain contracts not traded on an exchange to include contracts for which settlement is based on operations or activities specific to one of the parties to the contract. This improvement is expected to result in more contracts and embedded features being excluded from the scope of Topic 815. This ASU is effective for annual periods beginning after December 15, 2026, including interim periods within those fiscal years, with early adoption permitted. The Company is currently evaluating the effects adoption of this guidance will have on its consolidated financial statements.
In September 2025, the FASB issued ASU 2025-06 Intangibles—Goodwill and Other—Internal-Use Software Targeted Improvements to the Accounting for Internal-Use Software related to accounting for internal-use software costs. ASU 2025-06 improves the operability of the guidance by removing all references to software development project stages so that the guidance is neutral to different software development methods. This ASU is effective for annual periods beginning after December 15, 2027, including interim periods within those fiscal years, with early adoption permitted. The Company is currently evaluating the effects adoption of this guidance will have on its consolidated financial statements.
In November 2024, the FASB issued ASU 2024-03, Income Statement-Reporting Comprehensive Income-Expense Disaggregation Disclosures. ASU 2024-03 (as clarified by ASU 2025-01) is intended to improve disclosures about a public business entity’s expense and provide more detailed information to investors about the types of expenses in commonly presented expense captions. This ASU is effective for public companies with annual periods beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027, with early adoption permitted. The Company is currently evaluating the effects adoption of this guidance will have on its consolidated financial statements.
Reverse Stock Split
On June 3, 2026, the Company filed a Certificate of Amendment to its Amended and Restated Charter with the Secretary of State of the State of Delaware, which effected a 1-for-10 reverse stock split of its issued and outstanding common stock at 12:01 AM Eastern Time on June 17, 2026 (the "Reverse Stock Split"). All share and per share amounts presented in the accompanying condensed
8
consolidated financial statements and related notes have been retroactively adjusted to reflect the Reverse Stock Split for all periods presented. See Note 10. Stockholders' Deficit.
3. Fair Value Measurements
The Company recognizes financial instruments in accordance with the authoritative guidance on fair value measurements and disclosures for financial assets and liabilities. This guidance defines fair value, establishes a framework for measuring fair value in accordance with GAAP, and expands disclosures about fair value measurements. The guidance also establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value.
These tiers include Level 1, defined as observable inputs, such as quoted prices in active markets; Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable; and Level 3, defined as unobservable inputs in which little or no market data exists, therefore, requiring an entity to develop its own assumptions.
Assets measured at fair value on a recurring basis are summarized below (in thousands):
| Fair Value Measurements at September 30, 2026 | ||||||||||||||||||||||||||
| (unaudited) | ||||||||||||||||||||||||||
| Level 1 | Level 2 | Level 3 | Total | |||||||||||||||||||||||
| Assets: | ||||||||||||||||||||||||||
| Cash equivalents - money market funds | $ | $ | $ | $ | ||||||||||||||||||||||
| Interest rate derivatives | ||||||||||||||||||||||||||
| Total | $ | $ | $ | $ | ||||||||||||||||||||||
| Fair Value Measurements at December 31, 2025 | ||||||||||||||||||||||||||
| Level 1 | Level 2 | Level 3 | Total | |||||||||||||||||||||||
| Assets: | ||||||||||||||||||||||||||
| Cash equivalents - money market funds | $ | $ | $ | $ | ||||||||||||||||||||||
| Interest rate derivatives | ||||||||||||||||||||||||||
| Total | $ | $ | $ | $ | ||||||||||||||||||||||
Money market funds included in cash and cash equivalents are highly-liquid investments and are measured at fair value using quoted market prices in active markets, therefore are categorized as Level 1.
The fair value of the Company's interest rate derivatives is measured at the end of each interim reporting period based on the then assessed fair value. As the fair value measure is based on the market approach, they are categorized as Level 2.
The Company believes the carrying value of its long-term debt at September 30, 2026 approximates its fair value based on its variable interest rate feature and interest rates currently available to the Company. The estimated fair value of the Company's debt, before debt discount, at September 30, 2026 and December 31, 2025 was $225.4 million and $238.5 million, respectively, based on valuation methodologies using interest rates currently available to the Company which are Level 2 inputs.
The Company’s non-financial assets, such as property and equipment, goodwill and intangible assets, are recorded at fair value upon a business combination and are remeasured at fair value only if an impairment charge is recognized. The Company uses unobservable inputs to the valuation methodologies that are significant to the fair value measurements, and the valuations require management’s judgment due to the absence of quoted market prices. The Company determines the fair value of its held and used assets, goodwill and intangible assets using an income, cost or market approach as determined reasonable. As the fair value measures are based on unobservable inputs, they are categorized as Level 3.
9
Changes in the Company’s goodwill balance for the nine months ended September 30, 2026 are summarized in the table below (in thousands):
| Balance at December 31, 2025 | $ | |||||||||||||
| Impairment of goodwill | ( | |||||||||||||
| Foreign currency translation adjustment | ( | |||||||||||||
| Balance at September 30, 2026 | $ | |||||||||||||
The Company reviews its goodwill for impairment annually in the fourth quarter of the fiscal year and whenever events or changes in circumstances indicate that the carrying value of goodwill might not be recoverable. As a result of the sustained decline of the Company’s stock price impacting its market capitalization during the three months ended June 30, 2026, and the potential impact of its current operating results on the long-range forecast, the Company performed a quantitative impairment evaluation, which resulted in a goodwill impairment of $35.2 million for the three months ended June 30, 2026. The quantitative goodwill impairment analysis applied two methodologies to estimate the Company’s fair value which were: a) a discounted cash flow method and b) a guideline public company method. The two methods generated similar results and indicated that the fair value of the Company was less than its carrying value. The discounted cash flow method requires significant judgments, including estimation of future cash flows, which is dependent on internally developed forecasts, estimation of the long-term rate of growth for our business, and determination of the Company’s weighted average cost of capital. Under the guideline public company method, the Company estimates fair value based on a market multiple of revenues and earnings derived for comparable publicly traded companies with similar operating characteristics as the Company. The Company will continue to evaluate goodwill for impairment and adjust as indicators arise. If the Company’s stock price further declines or operational results do not meet expectations, additional material goodwill impairments could occur.
Intangible assets, net, include the estimated acquisition-date fair values of customer relationships, marketing-related assets, and developed technology that the Company recorded as part of its historical business acquisitions. The following is a summary of the Company’s intangible assets, net (in thousands):
| Estimated Useful Life (Years) | Gross Carrying Amount | Accumulated Amortization | Net Carrying Amount | ||||||||||||||||||||
| September 30, 2026: | |||||||||||||||||||||||
| Customer relationships | $ | $ | $ | ||||||||||||||||||||
| Trade name | |||||||||||||||||||||||
| Developed technology | |||||||||||||||||||||||
| Favorable leases | |||||||||||||||||||||||
| Total intangible assets | $ | $ | $ | ||||||||||||||||||||
| Estimated Useful Life (Years) | Gross Carrying Amount | Accumulated Amortization | Net Carrying Amount | ||||||||||||||||||||
| December 31, 2025: | |||||||||||||||||||||||
| Customer relationships | $ | $ | $ | ||||||||||||||||||||
| Trade name | |||||||||||||||||||||||
| Developed technology | |||||||||||||||||||||||
| Favorable leases | |||||||||||||||||||||||
| Total intangible assets | $ | $ | $ | ||||||||||||||||||||
The Company periodically reviews the estimated useful lives of its identifiable intangible assets, taking into consideration any events or circumstances that might result in either a diminished fair value or revised useful life. No impairments of identifiable intangibles were recorded during the three months ended September 30, 2026.
During the nine months ended September 30, 2025, the Company identified a triggering event related to certain identifiable intangible assets associated with Sunset Assets and performed a valuation of those long-lived assets in accordance with ASC 360 Impairment and Disposal of Long-Lived Assets. The Company used a discounted cash flow analysis to estimate the fair value of the long-lived asset group. As a result of the valuation, during the nine months ended September 30, 2025 the Company recorded a $2.5 million impairment charge related to identifiable intangible assets associated with certain Sunset Assets.
Total amortization expense was $6.1 million and $18.8 million during the three and nine months ended September 30, 2026, and $7.3 million and $24.6 million for the three and nine months ended September 30, 2025, respectively.
10
5. Income Taxes
The Company’s income tax provision for the three and nine months ended September 30, 2026 and September 30, 2025 reflects its estimate of the effective tax rates expected to be applicable for the full years, adjusted for any discrete events that are recorded in the period in which they occur. The estimates are re-evaluated each quarter based on the estimated tax expense for the full year.
The income tax provision of $0.9 million and $2.7 million for the three and nine months ended September 30, 2026 is primarily related to the income taxes associated with non-U.S. operations.
The income tax benefit of $0.3 million and $1.8 million for the three and nine months ended September 30, 2025 is largely comprised of the tax benefit due to divestitures of businesses during these periods. The income tax benefit for the three months ended September 30, 2025 also includes tax benefits generated from the impact of U.S. tax legislation, the One Big Beautiful Bill Act, enacted in July 2025. These tax benefits are offset by income taxes associated with U.S. and non-U.S. operations.
The Company historically incurred operating losses in the United States prior to 2021 and given its cumulative losses and limited history of profits, has recorded a valuation allowance against its United States net deferred tax assets at September 30, 2026 and December 31, 2025, respectively.
The Company has reflected uncertain tax positions primarily within its long-term taxes payable and a portion within deferred tax assets for which the balance is immaterial at September 30, 2026. The Company and its subsidiaries file tax returns in the U.S. federal jurisdiction, several U.S. state jurisdictions and several foreign jurisdictions. The Company is no longer subject to U.S. federal income tax examinations for years ending before December 31, 2022 and is no longer subject to state and local or foreign income tax examinations by tax authorities for years ending before December 31, 2019. U.S. operating losses generated in years prior to 2022 remain open to adjustment until the statute of limitations closes for the tax year in which the net operating losses are utilized.
6. Debt
Long-term debt consisted of the following (in thousands):
| September 30, 2026 | December 31, 2025 | |||||||||||||
Senior secured loans (includes unamortized discount and debt costs of $ | $ | $ | ||||||||||||
| Less current maturities | ( | ( | ||||||||||||
| Total long-term debt | $ | $ | ||||||||||||
On July 25, 2025, the Company entered into a Credit Agreement (the “Credit Agreement”) which provided for (i) a senior secured term loan facility in the aggregate principal amount of $240.0 million (the “Term Loan”) and (ii) a senior secured revolving credit facility in the aggregate principal amount of $30.0 million (the “Revolving Facility” and together with the Term Loan, the “Credit Facilities”).
The Term Loan matures on July 25, 2031 and bears an interest rate of the secured overnight financing rate, which shall not be less than 1.5 %, plus a margin of 6.0 % per annum (with step downs and a potential step up at specified leverage levels). At September 30, 2026, the floating interest rate was 10.1 %.
Payments on the Term Loan are due quarterly in amounts equal to (a) 2.50 % per annum of the original principal amount of the Term Loan commencing December 31, 2025 through September 30, 2026, (b) 1.75 % per annum of the original principal amount of the Term Loan commencing December 31, 2026 through September 30, 2027, and (c) 1.00 % per annum of the original principal amount of the Term Loan commencing December 31, 2027 and continuing each fiscal quarter thereafter, with the balance payable on the maturity date. Excess Cash Flow payments due under the terms of the Credit Agreement were nil and $3.3 million at September 30, 2026 and December 31, 2025, respectively, and are included in current maturities of notes payable in the condensed consolidated balance sheets.
The Revolving Facility matures on July 25, 2031 and bears the same interest rate as the Term Loan. No amounts were outstanding under the Revolving Facility as of September 30, 2026.
11
The Credit Facilities contain customary representations, warranties, covenants, including financial covenants, and events of default. The Credit Facilities are secured by substantially all of the Company’s assets, subject to certain exclusions. The Term Loan also includes (i) a covenant tested quarterly which limits the consolidated secured leverage ratio to 6.0 to 1.0 or under and (ii) certain other changes to the terms of the Credit Agreement, including with respect to certain negative covenants. The Revolving Facility is subject to the same covenants and terms as the Term Loan. As of September 30, 2026, the Company was in compliance with all covenants under the Credit Facilities.
The Company’s previous senior secured credit agreement provided for 7-year , senior secured term loans which were repaid July 25, 2025 with the proceeds of the Term Loan.
Lender fees and third party costs associated with the Term Loan are recorded as a direct deduction from the long-term debt and lender fees and third party costs associated with the Revolving Facility are recorded in other assets in the condensed consolidated balance sheets. All lender fees and third party costs are amortized into interest expense, net over the contractual term of the Credit Agreement.
Interest rate derivatives
In 2019, the Company entered into floating-to-fixed interest rate swap agreements to limit exposure to interest rate risk related to its debt through the maturity of the previous senior secured term loans, August 6, 2026. At the time the Company entered into the interest rate swap agreements, the Company designated all of the swaps as cash flow hedges. In August 2024, the Company de-designated all of the interest rate swaps. The realized and unrealized gains previously recognized in accumulated other comprehensive loss are being amortized to interest expense, net, as interest is accrued or prepayments are made on the Company’s debt. Subsequent to the de-designation, changes in the fair value of the interest rate swaps were recorded to interest expense, net. On July 18, 2025, the Company sold all of its remaining floating-to-fixed interest rate swap agreements.
Effective September 30, 2025, the Company entered into an interest rate cap agreement that expires on September 30, 2027 to limit exposure to interest rate risk, effectively capping the secured overnight financing rate at 4.5 % related to $120.0 million of their outstanding debt. The interest rate cap is reported at fair value and is included in interest rate derivatives on the condensed consolidated balance sheets, and the change in the fair value of the interest rate cap is reported in interest expense, net, on the condensed consolidated statements of operations.
The impact of the Company’s interest rate derivatives on its condensed consolidated statements of operations for the three and nine months ended September 30, 2026 and September 30, 2025 was as follows (in thousands):
| Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||||||||||||
| 2026 | 2025 | 2026 | 2025 | |||||||||||||||||||||||
| Unrealized gain (loss) in fair value of interest rate derivatives | $ | $ | $ | $ | ( | |||||||||||||||||||||
| Amounts reclassified from accumulated other comprehensive loss to interest expense, net | ||||||||||||||||||||||||||
| Cash payments on interest rate swaps | ||||||||||||||||||||||||||
| Total income (expense) from interest rate derivatives in interest expense, net | $ | $ | $ | $ | ||||||||||||||||||||||
7. Net Loss Per Share
The Company computes net loss per share of common stock, par value $0.0001 per share (“Common Stock”) and Series A Preferred Stock, par value $0.0001 per share (“Series A Preferred Stock”) using the two-class method. The two-class method requires income available to common stockholders for the period to be allocated between common stock and participating securities based upon their respective rights to receive dividends as if all income for the period had been distributed. The Company considers its Series A Preferred Stock to be a participating security, as its holders are entitled to fully participate in any dividends or other distributions declared or paid on its Common Stock on an as-converted basis.
All share and per share amounts presented herein have been retroactively adjusted to reflect the Reverse Stock Split.
12
The following table sets forth the computations of net loss per share (in thousands, except share and per share amounts):
| Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||||||||||||
| 2026 | 2025 | 2026 | 2025 | |||||||||||||||||||||||
| Numerator: | ||||||||||||||||||||||||||
| Net Loss | $ | ( | $ | ( | $ | ( | $ | ( | ||||||||||||||||||
| Preferred stock dividends and accretion | ( | ( | ( | ( | ||||||||||||||||||||||
| Net loss attributable to common stockholders | $ | ( | $ | ( | $ | ( | $ | ( | ||||||||||||||||||
| Denominator: | ||||||||||||||||||||||||||
| Weighted–average common shares outstanding, basic and diluted | ||||||||||||||||||||||||||
| Net loss per common share, basic and diluted | $ | ( | $ | ( | $ | ( | $ | ( | ||||||||||||||||||
Due to the net losses for the three and nine months ended September 30, 2026 and September 30, 2025, respectively, basic and diluted net loss per share were the same. The Company uses the application of the if-converted method for calculating diluted earnings per share on its Series A Preferred Stock. The Company applies the treasury stock method for calculating diluted earnings per share on its stock options, restricted stock units and performance-based restricted stock units.
Contingently issuable shares associated with outstanding performance-based restricted stock units (each, a “PSU”) were not included in the basic earnings per share calculations for the periods presented, as the applicable vesting conditions had not been satisfied.
Potential shares of common stock are excluded from the computation of diluted earnings per share when their effect would be antidilutive. Performance-based restricted stock units are considered dilutive when the related performance criteria have been met assuming the end of the reporting period represents the end of the performance period. All potential shares of common stock are antidilutive in periods of net loss. Potential shares of common stock not included in the computation of earnings per share because their effect would have been antidilutive or because the performance criterion was not met were as follows:
| September 30, | ||||||||||||||
| 2026 | 2025 | |||||||||||||
| Stock options | ||||||||||||||
Restricted stock units | ||||||||||||||
| Performance restricted stock units | ||||||||||||||
Series A Preferred Stock on an if-converted basis(1) | ||||||||||||||
| Total anti–dilutive common share equivalents | ||||||||||||||
(1) As of September 30, 2026, the Series A Preferred Stock plus accumulated dividends totaled $138.2 million. The Series A Preferred Stock has a conversion price of $175.00 per share, as detailed in “Note 9. Mezzanine Equity”.
8. Commitments and Contingencies
Purchase Commitments
The Company has purchase commitments related to hosting services, third-party technology used in the Company's solutions and for other services the Company purchases as part of normal operations. In certain cases, these arrangements require a minimum annual purchase commitment.
Litigation
In the normal course of business, the Company is involved in various lawsuits and legal proceedings. The Company does not anticipate that any current or pending legal proceedings will have a material adverse effect on the Company's condensed consolidated balance sheets or condensed consolidated statements of operations.
Letter of Credit
In conjunction with an operating lease agreement, the Company provided a $0.6 million letter of credit in conformance with the contractual provisions of the lease. The letter of credit expires July 2029. The amount underlying such letter of credit is reflected as restricted cash in the Company's consolidated balance sheets as of September 30, 2026.
13
9. Mezzanine Equity
Series A Convertible Preferred Stock
As of September 30, 2026 and December 31, 2025, there were 115,000 shares of Series A Preferred Stock of the Company, par value $0.0001 per share, issued and outstanding. The Series A Preferred Stock was issued on August 23, 2022 for an aggregate purchase price $115.0 million. In connection with the issuance of the Series A Preferred Stock, the Company incurred direct and incremental expenses of $4.6 million comprised of transaction fees, and financial advisory and legal expenses which reduced the carrying value of the Series A Preferred Stock. Holders of the Series A Preferred Stock have certain customary registration rights with respect to any shares of Series A Preferred Stock or the Common Stock of the Company issuable upon conversion of the Series A Preferred Stock, including rights with respect to the filing of a shelf registration statement, underwritten offering rights and piggy back rights.
Dividend Provisions
The Series A Preferred Stock ranks senior to the Company’s Common Stock with respect to payment of dividends and rights on the distribution of assets on any liquidation, dissolution or winding up of the affairs of the Company. The Series A Preferred Stock has an Initial Liquidation Preference of $1,000 per share. Holders of the Series A Preferred Stock are entitled to the dividend at the rate of 4.5 % per annum, within the first seven years after August 23, 2022 regardless of whether declared or assets are legally available for the payment. Such dividends shall accrue and compound quarterly in arrears from the date of issuance of the shares. The dividend rate will increase to 7.0 % on the seven-year anniversary of August 23, 2022. The dividend can be paid, in the Company’s sole discretion, in cash or dividend in kind by adding to the Liquidation Preference of each share of Series A Preferred Stock outstanding. On June 7, 2023, the stockholders of the Company authorized, for purposes of complying with Nasdaq Listing Rules 5635(b) and (d), the issuance of shares of Common Stock underlying shares of Series A Preferred Stock in an amount equal to or in excess of 20% of the Common Stock outstanding immediately prior to the issuance of such Series A Preferred Stock (including upon the operation of anti-dilution provisions contained in the Certificate of Designation designating the terms of such Series A Preferred Stock). The Series A Preferred Stock is also entitled to fully participate in any dividends paid to the holders of Common Stock in cash, in stock or otherwise, on an as-converted basis. The Series A Preferred Stock had accrued unpaid dividends of $23.2 million as of September 30, 2026, representing 132,543 Common Stock shares upon conversion at $175.00 per share.
Liquidation Rights
In the event of any Liquidation, holders of the Series A Preferred Stock are entitled to receive an amount per share equal to the greater of (1) the Initial Liquidation Preference per share plus any accrued or declared but unpaid dividends on such shares (the “Liquidation Preference”) or (2) the amount payable if the Series A Preferred Stock were converted into Common Stock. The Series A Preferred Stock will have distribution and liquidation rights senior to all other equity interests of the Company. As of September 30, 2026, the Liquidation Preference of the Series A Preferred Stock plus accrued and unpaid dividends was $138.2 million.
Optional Redemption
On or after the 7th anniversary of the original issue date of the Series A Preferred Stock, the Company has the right to redeem any outstanding shares of the Series A Preferred Stock for a cash purchase price equal to 105 % of the Liquidation Preference plus accrued and unpaid dividends as of the date of redemption.
Deemed Liquidation Event Redemption
Upon a fundamental change, holders of the Series A Preferred Stock have the right to require the Company to repurchase any or all of its Series A Preferred Stock for cash equal to the greater of (1) 105 % of the Liquidation Preference plus the present value of the dividend payments the holders would have been entitled to through the fifth anniversary of the issue date and (2) the amount that such Preferred Stock would have been entitled to receive as if converted into common shares immediately prior to the fundamental change.
A fundamental change (“Deemed Liquidation Event”) is defined as either the direct or indirect sale, lease, transfer, conveyance or other disposition of all or substantially all the properties or assets of the Company and its subsidiaries to any third party or the consummation of any transaction, the result of which is that any third party or group of third parties become the beneficial owner of more than 50 % of the voting power of the Company.
Voting Rights
The Series A Preferred Stock will vote together with the common shares on all matters and not as a separate class (except as specifically provided in the Certificate of Designation or as otherwise required by law) on an as-converted basis. The holders of the Series A Preferred Stock will have the right to elect one member of the Board of Directors of the Company (the “Board of Directors”) for so long as holders of the Series A Preferred Stock own in the aggregate at least 5 % of the shares of Common Stock on a fully diluted basis. In addition, the holders of the Series A Preferred Stock will have the right to elect one non-voting observer to the Board of Directors for so long as they hold at least 10 % of the shares of Convertible Preferred Stock outstanding as of the date of the issue date.
14
Conversion Feature
The Series A Preferred Stock may be converted, at any time in whole or in part at the option of the holder into a number of shares of Common Stock equal to the quotient obtained by dividing the sum of the Liquidation Preference plus all accrued and unpaid dividends by the conversion price of $175.00 (the “Conversion Price”). The Conversion Price is subject to adjustment in certain events.
Anti-Dilution Provisions
The Series A Preferred Stock has customary anti-dilution provisions for stock splits, stock dividends, mergers, sales of significant assets, and reorganization events and recapitalization transactions or similar events, and weighted average anti-dilution protection, subject to customary exceptions for issuances pursuant to current or future equity-based incentive plans or arrangements (including upon the exercise of employee stock options).
10. Stockholders' Deficit
Reverse Stock Split
On June 3, 2026, the Company filed a Certificate of Amendment to its Amended and Restated Charter with the Secretary of State of the State of Delaware, which effected a 1-for-10 reverse stock split of its issued and outstanding common stock at 12:01 AM Eastern Time on June 17, 2026. As a result of the Reverse Stock Split, every ten shares of the Company’s issued and outstanding common stock were automatically combined into one share of common stock, without any change in par value per share, which remained $0.0001 per share.
The Reverse Stock Split did not alter any stockholder’s percentage ownership interest in the Company, except to the extent that the Reverse Stock Split resulted in fractional shares. No fractional shares were issued in connection with the Reverse Stock Split, and stockholders who would otherwise have been entitled to receive a fractional share received a cash payment in lieu thereof.
All outstanding stock options, restricted stock units, and other equity-based awards, as well as the number of shares available for issuance under the Company’s 2024 Omnibus Incentive Plan, as amended, were proportionately adjusted in accordance with their respective terms.
All share and per share amounts presented in the accompanying condensed consolidated financial statements and related notes have been retroactively adjusted to reflect the Reverse Stock Split for all periods presented.
Common Stock
The common stock has a par value of $0.0001 per share. Each share of common stock is entitled to one vote at all meetings of stockholders. The number of authorized shares of common stock may be increased or decreased (but not below the number of shares thereof then outstanding) by the affirmative vote of the holders of shares of capital stock of the Company representing a majority of the votes represented by all outstanding shares of capital stock of the Company entitled to vote. The holders of common stock are also entitled to receive dividends, when, if and as declared by the board of directors, whenever funds are legally available therefore, subject to the priority rights of any outstanding preferred stock.
Share Repurchase Programs
On August 15, 2025, the Board of Directors authorized a stock repurchase program (the “2025 Share Repurchase Plan”) in the aggregate amount of up to $10 million (inclusive of any taxes payable as a result of such repurchase) that would allow the Company to repurchase shares of its issued and outstanding common stock, par value $0.0001 per share. The authorization does not have a specified expiration date. Accordingly, unless terminated earlier by resolution of the Board, the 2025 Share Repurchase Plan will expire when the Company has repurchased all shares authorized for repurchase thereunder. The Company is not obligated to acquire any particular amount of Common Stock and may modify or suspend the repurchases at any time in the Company’s discretion.
During the three months ended September 30, 2026, the Company purchased 98,009 shares as part of the 2025 Share Repurchase Plan at an average price of $3.59 per share, excluding commission costs and the impact of excise taxes. During the three months ended September 30, 2025, the Company purchased 5,560 shares as part of the 2025 Share Repurchase Plan at an average price of $24.40 per share, excluding commission costs and the impact of excise taxes after consideration of the Reverse Split in June 2026. As of September 30, 2026, $9.5 million was still available for share repurchases under the 2025 Share Repurchase Plan.
Tax Benefit Preservation Plan and Preferred Stock Purchase Rights
Effective June 5, 2024, the Company entered into the 2024 Tax Benefit Preservation Plan with Broadridge Corporate Issuer Solutions, LLC, as Rights Agent (the “2024 Tax Benefit Preservation Plan”). By adopting the 2024 Tax Benefit Preservation Plan, the Company is seeking to protect its ability to use its net operating loss carryforwards (“NOLs”) and other tax attributes to offset potential future income tax liabilities. The Company’s ability to use such NOLs and other tax attributes would be substantially limited if the Company experiences an “ownership change,” as defined in Section 382 of the Internal Revenue Code. The 2024 Tax Benefit Preservation Plan is intended to make it more difficult for the Company to undergo an ownership change by deterring any person from acquiring 4.9% or
15
more of the outstanding shares of stock without the approval of the Board of Directors. The following figures have been adjusted to reflect the Reverse Stock Split.
As part of the 2024 Tax Benefit Preservation Plan, the Board declared a dividend of one preferred stock purchase right (a “2024 Right” and collectively the “2024 Rights”) for each outstanding share of Common Stock payable as of June 15, 2024. In connection with the 2024 Tax Benefit Preservation Plan, 2,703,061 2024 Rights were issued. The description and terms of the 2024 Rights are set forth in the 2024 Tax Benefit Preservation Plan. The 2024 Rights trade with, and are inseparable from, the Common Stock, and the record holders of shares of Common Stock are the record holders of the 2024 Rights. The 2024 Rights are not exercisable until the Distribution Date, as defined in the 2024 Tax Benefit Preservation Plan.
After the Distribution Date, each 2024 Right will be exercisable to purchase from the Company one one-thousandth of a share of Series B Junior Participating Preferred Stock, par value $0.0001 per share, of the Company (the “Series B Preferred”), at a purchase price of $152.50 per one one-thousandth of a share of Series B Preferred, subject to adjustment as provided in the 2024 Tax Benefit Preservation Plan. Until a 2024 Right is exercised or exchanged, the holder thereof, as such, will have no rights as a stockholder of the Company by virtue of holding such Right, including, without limitation, the right to vote and to receive dividends. The Board may adjust the Purchase Price, the number of shares of Series B Preferred issuable and the number of outstanding 2024 Rights to prevent dilution that may occur from a stock dividend, a stock split, a reclassification of the Series B Preferred or Common Stock or certain other specified transactions. No adjustments to the Purchase Price of less than 1 % are required to be made.
Each one one-hundredth of a share of Series B Preferred, if issued:
•Will not be redeemable.
•Will entitle holders to quarterly dividend payments of $0.01 per one one-hundredth of a share of Series B Preferred, or an amount equal to the dividend paid on one share of Common Stock, whichever is greater.
•Will entitle holders upon liquidation either to receive $0.01 per one one-hundredth of a share of Series B Preferred, or an amount equal to the payment made on one share of Common Stock, whichever is greater.
•Will have the same voting power as one share of Common Stock.
•If shares of Common Stock are exchanged as a result of a merger, consolidation, or a similar transaction, will entitle holders to a per share payment equal to the payment made on one share of Common Stock.
Accumulated Other Comprehensive Income (Loss)
Comprehensive income consists of two elements, net loss and other comprehensive income (loss). Other comprehensive income (loss) items are recorded in the stockholders’ deficit section of the condensed consolidated balance sheets and are excluded from net loss. Other comprehensive income consists primarily of unrealized foreign currency translation adjustments for subsidiaries with functional currencies other than the U.S. dollar, unrealized translation gains (losses) on intercompany loans with foreign subsidiaries when repayment of those loans is not anticipated in the foreseeable future, and gains (losses) on interest rate swaps, net of amounts reclassified into interest expense, net.
The following table shows the components of accumulated other comprehensive loss, net of income taxes, (“AOCI”) in the stockholders’ deficit section of the condensed consolidated balance sheets at the dates indicated (in thousands):
| September 30, 2026 | December 31, 2025 | |||||||||||||
| Unrealized foreign currency translation adjustment, net of realized amounts reclassified into loss from divestitures of businesses | $ | ( | $ | ( | ||||||||||
| Unrealized translation losses on intercompany loans with foreign subsidiaries, net of taxes | ( | ( | ||||||||||||
| Unrealized gains on interest rate swaps, net of amounts reclassified into interest expense, net | ( | |||||||||||||
| Total accumulated other comprehensive loss | $ | ( | $ | ( | ||||||||||
The unrealized translation losses on intercompany loans considered long-term in nature with foreign subsidiaries as of September 30, 2026 and December 31, 2025 are net of income tax of $1.4 million and $1.5 million, respectively.
The functional currencies of foreign subsidiaries are the local currencies. Results of operations for foreign subsidiaries are translated into United States dollars (“USD”) using the average exchange rates on a monthly basis during the year. The assets and liabilities of those subsidiaries are translated into USD using the exchange rates in effect at the balance sheet date. The related translation adjustments are recorded in a separate component of stockholders' deficit in AOCI.
The income tax expense/benefit allocated to each component of other comprehensive income for all periods and components is not material. The Company reclassifies taxes from AOCI to earnings as the items to which the tax effects relate are similarly reclassified.
16
Stock-Based Compensation
The Company’s stock-based compensation generally includes awards of restricted stock units (“RSUs”) and performance-based restricted stock units (“PSUs”) under the Company’s 2024 Omnibus Incentive Plan. Key employees, officers and directors of the Company and its consultants or advisors are eligible to receive awards.
In May 2026, in connection with the hiring of the Company’s President and Chief Executive Officer, the Board of Directors granted 50,000 restricted stock units, which will vest in equal installments over three years , subject to continued service, and a grant of PSUs which will vest based on the achievement of certain market-based performance goals, with 13,333 PSUs eligible to vest at target performance and up to 50,000 PSUs eligible to vest at maximum performance. These grants are considered inducement grants pursuant to Nasdaq Listing Rule 5635(c)(4) whereby the underlying shares were authorized outside of the 2024 Omnibus Incentive Plan in connection with the commencement of the new President and Chief Executive Officer’s employment.
In August 2026, in connection with the hiring of the Company’s Chief Financial Officer, the Board of Directors granted 30,000 restricted stock units, which will vest in equal installments over three years , subject to continued service, and a grant of PSUs which will vest based on the achievement of certain market-based performance goals, with 6,666 PSUs eligible to vest at target performance and up to 25,000 PSUs eligible to vest at maximum performance. These grants were issued under the 2024 Omnibus Incentive Plan.
The following table summarizes all PSU and RSU activity during the nine months ended September 30, 2026:
| Number of Units | Weighted-Average Grant Date Fair Value | |||||||||||||
| Unvested restricted units outstanding as of December 31, 2025 | $ | |||||||||||||
| Granted | ||||||||||||||
| Vested | ( | |||||||||||||
| Forfeited | ( | |||||||||||||
| Unvested restricted units outstanding as of September 30, 2026 | $ | |||||||||||||
The PSU and RSU activity table above includes 19,999 PSUs granted in 2026 based on a 100 % target payout that are outstanding at September 30, 2026. During the nine months ended September 30, 2026, the Company cancelled 25,000 PSUs based on 100 % target payout that were previously granted to an executive officer in connection with the individual’s transition from Chief Executive Officer to a member of the Company’s Board of Directors.
Compensation cost related to awards is based on the fair market value at the time of the grant. The fair value of the RSUs is determined based on the grant date fair value of the award. Compensation expense for RSUs is recognized over the required service period of the grant. The PSUs vest upon the achievement of specified market performance thresholds. The PSUs have a vesting condition that is tied to the Company’s total shareholder return based on the Company’s stock performance up to a maximum of 375 %, depending on the specified performance condition and the level of achievement obtained. The fair value of PSUs is determined using the Monte Carlo simulation model. Compensation expense for PSUs is recognized over the requisite service period and is not subject to adjustment regardless of whether the PSUs meet the performance metric.
The significant assumptions used in the Monte Carlo simulation model for the PSUs granted during the nine months ended September 30, 2026 were as follows:
| Expected volatility | to | |||||||||||||||||||
| Risk-free interest rate | to | |||||||||||||||||||
| Remaining performance period (in years) | to | |||||||||||||||||||
| Dividend yield | to | |||||||||||||||||||
17
The Company recognizes stock-based compensation expense from all awards in the following expense categories included in the condensed consolidated statements of income (in thousands):
| Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||||||||||||
| 2026 | 2025 | 2026 | 2025 | |||||||||||||||||||||||
| Cost of revenue | $ | $ | $ | $ | ||||||||||||||||||||||
| Research and development | ||||||||||||||||||||||||||
| Sales and marketing | ||||||||||||||||||||||||||
| General and administrative | ||||||||||||||||||||||||||
| Total | $ | $ | $ | $ | ||||||||||||||||||||||
11. Revenue Recognition
Deferred Commissions
Amortization of deferred commissions in excess of commissions capitalized for the three and nine months ended September 30, 2026 was $0.2 million and $0.8 million, respectively, and for the three and nine months ended September 30, 2025 was $0.1 million and $1.2 million, respectively.
Deferred Revenue
Deferred revenue represents either customer advance payments or billings for which the aforementioned revenue recognition criteria have not yet been met.
Remaining Performance Obligations
12. Divestitures
During the nine months ended September 30, 2026, the Company did not execute any divestitures. During the nine months ended September 30, 2025, the Company completed the divestitures of certain product lines. The combined net loss on divestitures was $24.4 million for the nine months ended September 30, 2025. The Company incurred divestiture-related expenses of $9.4 million during the nine months ended September 30, 2025 which are recorded in divestiture-related expenses on the Company’s condensed consolidated statements of operations.
Proceeds for divestitures completed in 2025 included a secured promissory note in the original principal amount of $5.5 million to be repaid quarterly over 5 years bearing interest at 10 % annually through maturity in July 2030. At September 30, 2026, the book value of the note receivable was $2.5 million including a reserve for potential credit loss. The Company monitors the collectability of the note and will record adjustments to the estimated net realizable value as deemed necessary until the note is settled. At September 30, 2026, the current portion of the promissory note less associated reserve was $0.5 million and is recorded in prepaid and other current
18
assets on the Company’s condensed consolidated balance sheets and the long-term portion of the promissory note less associated reserve was $2.0 million and is recorded in other assets on the Company’s condensed consolidated balance sheets.
13. Segment Information
The Company’s Chief Executive Officer is considered to be the Company’s chief operating decision-maker (“CODM”). The CODM manages the business as a multi-product cloud-based software application business that utilizes a singular operating model to deliver a consistently high level of operating performance to customers regardless of their geography or IT environment. Operating results are reviewed by the CODM primarily at the consolidated entity level for purposes of making resource allocation decisions and for evaluating financial performance. Accordingly, the Company has determined that it is a single operating and reporting segment structure. The key measure of profit or loss utilized by the CODM to assess performance of and allocate resources within the Company’s single operating segment is net loss. This measure is presented on the condensed consolidated statements of operations. Significant segment expenses included in net loss are cost of revenue, sales and marketing expenses, research and development expenses, general and administrative expenses, depreciation and amortization, interest expense, net and other income (expense), which are presented on the condensed consolidated statements of operations. The measure of segment assets is reported on the condensed consolidated balance sheets as total assets.
19
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
Forward-Looking Statements
The following discussion and analysis of our financial condition and results of operations should be read in conjunction with the unaudited condensed consolidated financial statements and the notes thereto appearing elsewhere in this Quarterly Report on Form 10-Q and our other filings with the Securities and Exchange Commission (“SEC”), including our Annual Report on Form 10-K for the year ended December 31, 2025. In addition to historical information, this Quarterly Report on Form 10-Q contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Forward-looking statements generally relate to future events or our future financial or operating performance. Forward-looking statements may be identified by the use of forward-looking words such as “anticipate,” “believe,” “may,” “will,” “continue,” “seek,” “estimate,” “intend,” “hope,” “predict,” “could,” “should,” “would,” “project,” “plan,” “expect” or the negative or plural of these words or similar expressions, although not all forward-looking statements contain these words.
You should not rely upon forward-looking statements as predictions of future events. We have based the forward-looking statements contained in this Quarterly Report on Form 10-Q primarily on our current expectations and projections about future events and trends that we believe may affect our business, financial condition, results of operations, and prospects. The outcome of the events described in these forward-looking statements is subject to risks, uncertainties, and other factors, including those described in the section titled “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2025. We cannot assure you that the results, events and circumstances reflected in the forward-looking statements will be achieved or occur, and actual results, events or circumstances could differ materially from those described in the forward-looking statements.
The forward-looking statements made in this Quarterly Report on Form 10-Q relate only to events as of the date on which the statements are made. We undertake no obligation to update any forward-looking statements made in this Quarterly Report on Form 10-Q to reflect events or circumstances after the date of this Quarterly Report on Form 10-Q or to reflect new information or the occurrence of unanticipated events, except as required by law. We may not actually achieve the plans, intentions, or expectations disclosed in our forward-looking statements and you should not place undue reliance on our forward-looking statements. Our forward-looking statements do not reflect the potential impact of any future acquisitions, mergers, dispositions, joint ventures or investments we may make.
Overview
Upland Software, Inc. provides an intelligence layer that unifies and contextualizes enterprise knowledge, content, and data, turning isolated information into actionable outcomes for every human and agent. More than 1,100 enterprise customers rely on Upland's deep domain expertise to drive measurable, value-add outcomes, unlocking the full potential of AI as their organizations evolve.
On June 3, 2026, we filed a Certificate of Amendment to our Amended and Restated Charter with the Secretary of State of the State of Delaware, which effected a 1-for-10 reverse stock split of our issued and outstanding common stock (the "Reverse Stock Split"). As a result of the Reverse Stock Split, every ten shares of our issued and outstanding common stock were automatically combined into one share of common stock, without any change in par value per share, which remained $0.0001 per share. The Reverse Stock Split did not alter any stockholder’s percentage ownership interest in the Company, except to the extent that the Reverse Stock Split resulted in fractional shares. No fractional shares were issued in connection with the Reverse Stock Split, and stockholders who would otherwise have been entitled to receive a fractional share received a cash payment in lieu thereof. All outstanding stock options, restricted stock units, and other equity-based awards, as well as the number of shares available for issuance under our 2024 Omnibus Incentive Plan, as amended, were proportionately adjusted in accordance with their respective terms.
Other
On July 31, 2026, the Company received a notification letter from the Nasdaq Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that the Company no longer meets Nasdaq’s $15 million minimum market value of publicly held shares requirement under Nasdaq Listing Rule 5450(b)(2&3)(C) (the “MVPHS Requirement”) based on Nasdaq’s review of the market value of the Company’s publicly held shares for the previous 30 consecutive business days. The Nasdaq deficiency letter is a notice of deficiency, not delisting, and does not currently affect the listing or trading of the Company’s common stock on the Nasdaq Global Market. The Company’s common stock will continue to trade on the Nasdaq Global Market under the symbol “UPLD” at this time.
The Company has 180 days, or until January 27, 2027, to regain compliance with the MVPHS Requirement (the “Compliance Date”). If, at any time before the Compliance Date, the Company’s market value of publicly held shares closes at $15 million or more for a minimum of ten consecutive business days, but generally no more than 20 consecutive business days, Nasdaq will provide written notification to the Company that it has regained compliance with the MVPHS Requirement. If the Company does not regain compliance with the MVPHS Requirement by the Compliance Date, Nasdaq will provide written notification to the Company that the Company’s common stock will be subject to delisting. At that time, the Company may appeal the delisting determination to a Nasdaq Hearings Panel (the “Panel”). However, there can be no assurance that, if the Company receives a delisting notice and appeals the delisting determination to the Panel, such appeal would be successful.
20
The Company intends to actively monitor the market value of its publicly held shares and to consider plans for regaining compliance with the MVPHS Requirement. While the Company plans to review all available options, there can be no assurance that it will be able to regain compliance with the applicable rules before the Compliance Date, any additional compliance period, or at all.
Key Metrics and Non-GAAP Financial Measures
In addition to the GAAP financial measures described below in “Results of Operations,” we regularly review the following key metrics and non-GAAP financial measures to evaluate and identify trends in our business, measure our performance, prepare financial projections and make strategic decisions.
Core Organic Growth Rate
We use Core Organic Growth Rate as a key performance measure to assess our consolidated operating performance over time and for planning and forecasting purposes. Core Organic Growth Rate is the percentage change between two reported periods in subscription and support revenue, excluding subscription and support revenue from Sunset Assets, subscription and support revenue from divestitures, and Overage Charges, each as defined below. We calculate our year-over-year Core Organic Growth Rate as though all acquisitions or dispositions closed as of the end of the latest period were closed as of the first day of the prior year period presented. Core Organic Growth Rate does not represent actual organic revenue generated by our business as it stood at the beginning of the respective period.
For the three-month period ended September 30, 2026, our Core Organic Growth Rate was negative 3.86%.
Core Organic Growth Rates are not necessarily indicative of either future results of operations or actual results that might have been achieved had certain Sunset Asset classifications not been made or had certain acquisitions or dispositions been consummated on the first day of the prior year period presented. We believe that this metric is useful to management and investors in analyzing our financial and operational performance period-over-period along with evaluating the growth of our business normalized for the impact of acquisitions and dispositions, as well as adjusting for the exclusion of non-core Sunset Assets and non-committed Overage Charges.
Related Defined Terms
In connection with periodic reviews of our business, we have decided to discontinue the availability of certain non-strategic product offerings and a limited number of non-strategic customer contracts (collectively referred to as “Sunset Assets”). It is possible that during future periodic reviews of our business we may determine to add additional non-strategic product offerings or non-strategic customer contracts to Sunset Assets or remove certain product offerings or customer contracts from the classification of Sunset Assets. In either case, we will adjust the revenues attributable to Sunset Assets and properly reflect the year over year change for such addition or removal.
Overage Charges are subscription and support revenues earned in addition to contractual minimum customer commitments as a result of the usage volume of services including text and e-mail messaging and third-party pass-through costs that exceed the levels stipulated in contracts with the Company.
The following table represents a reconciliation of total revenue, the most comparable GAAP measure, to core organic revenue for each of the periods indicated.
| Three Months Ended September 30, | |||||||||||||||||||||||
| 2026 | 2025 | ||||||||||||||||||||||
| (dollars in thousands) | |||||||||||||||||||||||
| Reconciliation of total revenue to core organic revenue: | |||||||||||||||||||||||
| Total revenue | $ | 47,525 | $ | 50,526 | |||||||||||||||||||
| Less: | |||||||||||||||||||||||
| Perpetual license revenue | 1,180 | 1,160 | |||||||||||||||||||||
| Professional services revenue | 1,086 | 1,641 | |||||||||||||||||||||
| Subscription and support revenue from Sunset Assets | 1,683 | 2,139 | |||||||||||||||||||||
| Subscription and support revenue from divestitures | — | 231 | |||||||||||||||||||||
| Overage Charges | 143 | 179 | |||||||||||||||||||||
| Core organic revenue | $ | 43,433 | $ | 45,176 | |||||||||||||||||||
21
Adjusted EBITDA
We monitor our Adjusted EBITDA to help us evaluate the effectiveness and efficiency of our operations. Adjusted EBITDA is a non-GAAP financial measure. We define Adjusted EBITDA as net loss, calculated in accordance with GAAP, adjusted for depreciation and amortization expense, net interest expense, loss on debt extinguishment, net other expense (income), benefit from (provision for) income taxes, stock-based compensation expense, non-recurring litigation costs, acquisition and divestiture related expense, purchase accounting deferred revenue discount, gains and losses on divestitures of businesses, and impairment charges.
The following table represents a reconciliation of net loss, the most comparable GAAP measure, to Adjusted EBITDA for each of the periods indicated.
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
| 2026 | 2025 | 2026 | 2025 | ||||||||||||||||||||
| (dollars in thousands) | |||||||||||||||||||||||
| Reconciliation of Net Loss to Adjusted EBITDA: | |||||||||||||||||||||||
| Net loss | $ | (451) | $ | (1,122) | $ | (36,999) | $ | (39,999) | |||||||||||||||
| Add: | |||||||||||||||||||||||
| Depreciation and amortization expense | 6,295 | 7,552 | 19,349 | 25,367 | |||||||||||||||||||
| Interest expense (income), net | 5,083 | 4,204 | 14,068 | 10,783 | |||||||||||||||||||
| Loss on debt extinguishment | — | 2,301 | — | 2,301 | |||||||||||||||||||
| Other expense (income), net | (154) | (249) | 937 | 1,587 | |||||||||||||||||||
| Provision for (benefit from) income taxes | 855 | (259) | 2,682 | (1,775) | |||||||||||||||||||
| Stock-based compensation expense | 723 | 2,323 | 2,514 | 8,072 | |||||||||||||||||||
| Divestiture-related expenses | — | 778 | 22 | 9,402 | |||||||||||||||||||
| Non-recurring litigation costs | 245 | 4 | 246 | 34 | |||||||||||||||||||
| Purchase accounting deferred revenue discount | 5 | 27 | 26 | 93 | |||||||||||||||||||
| Loss on divestitures of businesses | — | 473 | — | 24,364 | |||||||||||||||||||
| Impairment of goodwill and other intangibles | — | — | 35,246 | 2,469 | |||||||||||||||||||
| Adjusted EBITDA | $ | 12,601 | $ | 16,032 | $ | 38,091 | $ | 42,698 | |||||||||||||||
We believe that Adjusted EBITDA provides useful information to management, investors and others in understanding and evaluating our operating results for the following reasons:
•Adjusted EBITDA is widely used by investors and securities analysts to measure a company’s operating performance without regard to items that can vary substantially from company to company depending upon their financing, capital structures and the method by which assets were acquired;
•Our management uses Adjusted EBITDA in conjunction with GAAP financial measures for planning purposes, in the preparation of our annual operating budget, as a measure of our operating performance, to assess the effectiveness of our business strategies and to communicate with our board of directors concerning our financial performance because Adjusted EBITDA eliminates the impact of items that we do not consider indicative of our core operating performance;
•Adjusted EBITDA provides more consistency and comparability with our past financial performance, facilitates period-to-period comparisons of our operations and also facilitates comparisons with other companies, many of which use similar non-GAAP financial measures to supplement their GAAP results.
Adjusted EBITDA should not be considered as an alternative to net loss or any other measure of financial performance calculated and presented in accordance with GAAP. The use of Adjusted EBITDA as an analytical tool has limitations such as:
•Impairment of goodwill and other intangibles and depreciation and amortization are non-cash charges, and the assets being depreciated or amortized, which contribute to the generation of revenue, will often have to be replaced in the future and Adjusted EBITDA does not reflect cash requirements for such replacements; however, much of the depreciation and amortization relates to amortization of acquired intangible assets as well as the goodwill as a result of business combination purchase accounting adjustments, which will not need to be replaced in the future;
•Adjusted EBITDA may not reflect changes in, or cash requirements for, our working capital needs or contractual commitments;
•Adjusted EBITDA does not reflect the potentially dilutive impact of stock-based compensation;
•Adjusted EBITDA does not reflect interest or tax payments that could reduce cash available for use; and
22
•Other companies, including companies in our industry, might calculate Adjusted EBITDA or similarly titled measures differently, which reduces their usefulness as comparative measures.
Because of these limitations, you should consider Adjusted EBITDA together with other financial performance measures, including various cash flow metrics, net loss, and our other GAAP results.
Results of Operations
Consolidated Statements of Operations Data
The following table sets forth our results of operations for the specified periods, as well as our results of operations for the specified periods as a percentage of revenue. The period-to-period comparisons of results of operations are not necessarily indicative of results for future periods.
| Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||||||||||||||||||||||||||||||||||||
| 2026 | 2025 | 2026 | 2025 | |||||||||||||||||||||||||||||||||||||||||||||||
| Amount | Percent of Revenue | Amount | Percent of Revenue | Amount | Percent of Revenue | Amount | Percent of Revenue | |||||||||||||||||||||||||||||||||||||||||||
| (dollars in thousands, except share and per share data) | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Revenue: | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Subscription and support | $ | 45,259 | 95 | % | $ | 47,725 | 94 | % | $ | 137,502 | 95 | % | $ | 158,374 | 95 | % | ||||||||||||||||||||||||||||||||||
| Perpetual license | 1,180 | 2 | % | 1,160 | 2 | % | 4,213 | 3 | % | 3,967 | 2 | % | ||||||||||||||||||||||||||||||||||||||
| Total product revenue | 46,439 | 97 | % | 48,885 | 96 | % | 141,715 | 98 | % | 162,341 | 97 | % | ||||||||||||||||||||||||||||||||||||||
| Professional services | 1,086 | 3 | % | 1,641 | 4 | % | 3,641 | 2 | % | 5,223 | 3 | % | ||||||||||||||||||||||||||||||||||||||
| Total revenue | 47,525 | 100 | % | 50,526 | 100 | % | 145,356 | 100 | % | 167,564 | 100 | % | ||||||||||||||||||||||||||||||||||||||
| Cost of revenue: | ||||||||||||||||||||||||||||||||||||||||||||||||||
Subscription and support (1)(2) | 10,706 | 23 | % | 10,774 | 21 | % | 32,689 | 22 | % | 40,136 | 24 | % | ||||||||||||||||||||||||||||||||||||||
Professional services and other (1) | 813 | 1 | % | 903 | 2 | % | 2,434 | 2 | % | 3,024 | 2 | % | ||||||||||||||||||||||||||||||||||||||
| Total cost of revenue | 11,519 | 24 | % | 11,677 | 23 | % | 35,123 | 24 | % | 43,160 | 26 | % | ||||||||||||||||||||||||||||||||||||||
| Gross profit | 36,006 | 76 | % | 38,849 | 77 | % | 110,233 | 76 | % | 124,404 | 74 | % | ||||||||||||||||||||||||||||||||||||||
| Operating expenses: | ||||||||||||||||||||||||||||||||||||||||||||||||||
Sales and marketing (1) | 8,976 | 19 | % | 9,707 | 19 | % | 27,957 | 19 | % | 34,234 | 20 | % | ||||||||||||||||||||||||||||||||||||||
Research and development (1) | 7,781 | 16 | % | 7,872 | 16 | % | 23,591 | 16 | % | 29,195 | 17 | % | ||||||||||||||||||||||||||||||||||||||
General and administrative (1) | 8,398 | 18 | % | 8,787 | 17 | % | 26,001 | 18 | % | 30,627 | 18 | % | ||||||||||||||||||||||||||||||||||||||
| Depreciation and amortization | 5,518 | 12 | % | 6,357 | 13 | % | 16,728 | 12 | % | 21,216 | 13 | % | ||||||||||||||||||||||||||||||||||||||
| Divestiture-related expenses | — | — | % | 778 | 1 | % | 22 | — | % | 9,402 | 7 | % | ||||||||||||||||||||||||||||||||||||||
| Impairment of goodwill and other intangibles | — | — | % | — | — | % | 35,246 | 24 | % | 2,469 | 1 | % | ||||||||||||||||||||||||||||||||||||||
| Total operating expenses | 30,673 | 65 | % | 33,501 | 66 | % | 129,545 | 89 | % | 127,143 | 76 | % | ||||||||||||||||||||||||||||||||||||||
| Income (loss) from operations | 5,333 | 11 | % | 5,348 | 11 | % | (19,312) | (13) | % | (2,739) | (2) | % | ||||||||||||||||||||||||||||||||||||||
| Other income (expense): | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Interest expense, net | (5,083) | (11) | % | (4,204) | (8) | % | (14,068) | (10) | % | (10,783) | (6) | % | ||||||||||||||||||||||||||||||||||||||
| Loss on divestitures of businesses | — | — | % | (473) | (1) | % | — | — | % | (24,364) | (15) | % | ||||||||||||||||||||||||||||||||||||||
| Loss on debt extinguishment | — | — | % | (2,301) | (5) | % | — | — | % | (2,301) | (1) | % | ||||||||||||||||||||||||||||||||||||||
| Other income (expense), net | 154 | — | % | 249 | — | % | (937) | — | % | (1,587) | (1) | % | ||||||||||||||||||||||||||||||||||||||
| Total other expense, net | (4,929) | (11) | % | (6,729) | (14) | % | (15,005) | (10) | % | (39,035) | (23) | % | ||||||||||||||||||||||||||||||||||||||
| Income (loss) before benefit from (provision for) income taxes | 404 | — | % | (1,381) | (3) | % | (34,317) | (23) | % | (41,774) | (25) | % | ||||||||||||||||||||||||||||||||||||||
| Benefit from (provision for) income taxes | (855) | (1) | % | 259 | 1 | % | (2,682) | (2) | % | 1,775 | 1 | % | ||||||||||||||||||||||||||||||||||||||
| Net loss | $ | (451) | (1) | % | $ | (1,122) | (2) | % | $ | (36,999) | (25) | % | $ | (39,999) | (24) | % | ||||||||||||||||||||||||||||||||||
| Preferred stock dividends | (1,538) | (3) | % | (1,470) | (3) | % | (4,562) | (3) | % | (4,362) | (3) | % | ||||||||||||||||||||||||||||||||||||||
| Net loss attributable to common stockholders | $ | (1,989) | (4) | % | $ | (2,592) | (5) | % | $ | (41,561) | (29) | % | $ | (44,361) | (26) | % | ||||||||||||||||||||||||||||||||||
| Net loss per common share: | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Net loss per common share, basic and diluted | $ | (0.67) | $ | (0.90) | $ | (14.15) | $ | (15.56) | ||||||||||||||||||||||||||||||||||||||||||
| Weighted-average common shares outstanding, basic and diluted | 2,953,833 | 2,878,486 | 2,936,566 | 2,851,028 | ||||||||||||||||||||||||||||||||||||||||||||||
(1) Includes stock-based compensation detailed under Stock-Based Compensation in “Item 1. Financial Statements—Note 10. Stockholders' Deficit”. | ||||||||||||||||||||||||||||||||||||||||||||||||||
(2) Includes amortization as detailed in Cost of Revenue below. | ||||||||||||||||||||||||||||||||||||||||||||||||||
23
Comparison of the Three and Nine Months Ended September 30, 2026 and 2025
See Note 12. Divestitures regarding product lines divested in the nine months ended September 30, 2025.
Revenue
| Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||||||||||||||||||||||||
| 2026 | 2025 | % Change | 2026 | 2025 | % Change | |||||||||||||||||||||||||||||||||
| (dollars in thousands) | ||||||||||||||||||||||||||||||||||||||
| Revenue: | ||||||||||||||||||||||||||||||||||||||
| Subscription and support | $ | 45,259 | $ | 47,725 | (5) | % | $ | 137,502 | $ | 158,374 | (13) | % | ||||||||||||||||||||||||||
| Perpetual license | 1,180 | 1,160 | 2 | % | 4,213 | 3,967 | 6 | % | ||||||||||||||||||||||||||||||
| Total product revenue | 46,439 | 48,885 | (5) | % | 141,715 | 162,341 | (13) | % | ||||||||||||||||||||||||||||||
| Professional services | 1,086 | 1,641 | (34) | % | 3,641 | 5,223 | (30) | % | ||||||||||||||||||||||||||||||
| Total revenue | $ | 47,525 | $ | 50,526 | (6) | % | $ | 145,356 | $ | 167,564 | (13) | % | ||||||||||||||||||||||||||
For the Three Months Ended September 30, 2026
Total revenue was $47.5 million in the three months ended September 30, 2026, compared to $50.5 million in the three months ended September 30, 2025, a decrease of $3.0 million, or 6%. This decrease is primarily due to declines in subscription and support revenue of $1.8 million and professional services revenue of $0.6 million primarily reflecting customer attrition in certain core products. The remaining $0.6 million reflects the planned wind-down of Sunset Assets of $0.4 million and divested product lines of $0.2 million consistent with our strategy to focus on our core portfolio.
For the Nine Months Ended September 30, 2026
Total revenue was $145.4 million in the nine months ended September 30, 2026, compared to $167.6 million in the nine months ended September 30, 2025, a decrease of $22.2 million, or 13%. Approximately 87% of the decrease, $19.4 million, reflects the 2025 divestitures of $18.0 million and planned wind-down of Sunset Assets of $1.4 million consistent with our strategy to focus on higher-margin, higher-growth product lines. The remaining decrease results from declines in professional services revenue of $1.2 million and subscription and support revenue of $1.8 million related to core products offset by an increase in perpetual license revenue of $0.2 million from core products.
Cost of Revenue
| Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||||||||||||||||||||||||
| 2026 | 2025 | % Change | 2026 | 2025 | % Change | |||||||||||||||||||||||||||||||||
| (dollars in thousands) | ||||||||||||||||||||||||||||||||||||||
| Cost of revenue: | ||||||||||||||||||||||||||||||||||||||
Subscription and support (1) | $ | 10,706 | $ | 10,774 | (1) | % | $ | 32,689 | $ | 40,136 | (19) | % | ||||||||||||||||||||||||||
| Professional services and other | 813 | 903 | (10) | % | 2,434 | 3,024 | (20) | % | ||||||||||||||||||||||||||||||
| Total cost of revenue | 11,519 | 11,677 | (1) | % | 35,123 | 43,160 | (19) | % | ||||||||||||||||||||||||||||||
| Gross profit | $ | 36,006 | $ | 38,849 | (7) | % | $ | 110,233 | $ | 124,404 | (11) | % | ||||||||||||||||||||||||||
(1) Includes amortization and stock-based compensation expense as follows: | ||||||||||||||||||||||||||||||||||||||
| Amortization | $ | 777 | $ | 1,195 | $ | 2,621 | $ | 4,151 | ||||||||||||||||||||||||||||||
| Stock-based compensation | $ | 63 | $ | 69 | $ | 221 | $ | 333 | ||||||||||||||||||||||||||||||
For the Three Months Ended September 30, 2026
Cost of subscription and support revenue was $10.7 million in the three months ended September 30, 2026, compared to $10.8 million in the three months ended September 30, 2025, a decrease of $0.1 million, or 1%. The decrease related to divested product lines was $0.1 million attributable to infrastructure costs and personnel costs. The decrease related to Sunset Assets was $0.1 million, primarily attributable to personnel-related costs and non-cash amortization of intangibles. A decrease of $0.4 million in non-cash amortization of intangibles in our core product lines was offset by a $0.4 million increase in infrastructure costs and a $0.1 million increase in variable telecom carrier costs.
Cost of professional services and other revenue was $0.8 million in the three months ended September 30, 2026, compared to $0.9 million in the three months ended September 30, 2025, a decrease of $0.1 million, or 10%. The decrease in cost of professional
24
services and other revenue was comprised of a decrease of $0.1 million in our core product lines due to lower professional services revenue in our core products.
For the Nine Months Ended September 30, 2026
Cost of subscription and support revenue was $32.7 million in the nine months ended September 30, 2026, compared to $40.1 million in the nine months ended September 30, 2025, a decrease of $7.4 million, or 19%. The decrease related to divested product lines was $7.4 million attributable to infrastructure costs, variable telecom carrier costs, personnel costs and non-cash amortization of divested intangibles. The decrease related to Sunset Assets was $0.4 million. These decreases were offset by increases in our core product lines of $1.2 million in infrastructure costs, $0.1 million increase in professional fees, and $0.1 million increase in variable telecommunications costs which were offset by a $1.0 million decline in non-cash amortization of intangibles.
Cost of professional services and other revenue was $2.4 million in the nine months ended September 30, 2026, compared to $3.0 million in the nine months ended September 30, 2025, a decrease of $0.6 million, or 20%. The decrease in cost of professional services and other revenue was comprised of a decrease in personnel-related expenses of $0.5 million in our core product lines and $0.1 million in our divested product lines.
Operating Expenses
Sales and Marketing Expense
| Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||||||||||||||||||||||||
| 2026 | 2025 | % Change | 2026 | 2025 | % Change | |||||||||||||||||||||||||||||||||
| (dollars in thousands) | ||||||||||||||||||||||||||||||||||||||
Sales and marketing (1) | $ | 8,976 | $ | 9,707 | (8) | % | $ | 27,957 | $ | 34,234 | (18) | % | ||||||||||||||||||||||||||
(1) Includes stock-based compensation expense as follows: | ||||||||||||||||||||||||||||||||||||||
| Stock-based compensation | $ | 13 | $ | 80 | $ | 56 | $ | 384 | ||||||||||||||||||||||||||||||
For the Three Months Ended September 30, 2026
Sales and marketing expense was $9.0 million in the three months ended September 30, 2026, compared to $9.7 million in the three months ended September 30, 2025, a decrease of $0.7 million, or 8%. The decrease related to core product lines was $0.6 million in personnel-related costs reflecting reorganization around our core portfolio. The remaining decrease was due to declines in personnel-related costs of $0.1 million related to our Sunset Assets.
For the Nine Months Ended September 30, 2026
Sales and marketing expense was $28.0 million in the nine months ended September 30, 2026, compared to $34.2 million in the nine months ended September 30, 2025, a decrease of $6.3 million, or 18%. The decrease related to divested product lines was $3.5 million comprised of $3.3 million in personnel-related costs and $0.2 million in marketing spend and other sales costs. The remaining decrease was primarily related to a decrease of $2.6 million in costs related to our core product lines comprised of $2.5 million in personnel-related costs and $0.2 million infrastructure costs offset by $0.1 million in marketing costs, as well as a $0.2 million decrease in personnel-related costs associated with Sunset Assets.
Research and Development Expense
| Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||||||||||||||||||||||||
| 2026 | 2025 | % Change | 2026 | 2025 | % Change | |||||||||||||||||||||||||||||||||
| (dollars in thousands) | ||||||||||||||||||||||||||||||||||||||
Research and development (1) | $ | 7,781 | $ | 7,872 | (1) | % | $ | 23,591 | $ | 29,195 | (19) | % | ||||||||||||||||||||||||||
(1) Includes stock-based compensation expense as follows: | ||||||||||||||||||||||||||||||||||||||
| Stock-based compensation | $ | 46 | $ | 89 | $ | 186 | $ | 697 | ||||||||||||||||||||||||||||||
For the Three Months Ended September 30, 2026
Research and development expense was $7.8 million in the three months ended September 30, 2026, compared to $7.9 million in the three months ended September 30, 2025, a decrease of $0.1 million, or 1%. The decrease in research and development expense was primarily attributable to a $0.1 million decrease in personnel-related costs in our core product lines.
25
For the Nine Months Ended September 30, 2026
Research and development expense was $23.6 million in the nine months ended September 30, 2026, compared to $29.2 million in the nine months ended September 30, 2025, a decrease of $5.6 million, or 19%. The decrease in research and development expense was primarily attributable to a $2.9 million decrease in personnel-related costs in our core product lines reflecting the termination of our out-sourced research and development contract and a $2.6 million decrease in personnel-related costs and $0.1 million decrease in infrastructure costs in our divested product lines.
General and Administrative Expense
| Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||||||||||||||||||||||||
| 2026 | 2025 | % Change | 2026 | 2025 | % Change | |||||||||||||||||||||||||||||||||
| (dollars in thousands) | ||||||||||||||||||||||||||||||||||||||
General and administrative (1) | $ | 8,398 | $ | 8,787 | (4) | % | $ | 26,001 | $ | 30,627 | (15) | % | ||||||||||||||||||||||||||
(1) Includes stock-based compensation expense as follows: | ||||||||||||||||||||||||||||||||||||||
| Stock-based compensation | $ | 601 | $ | 2,085 | $ | 2,051 | $ | 6,658 | ||||||||||||||||||||||||||||||
For the Three Months Ended September 30, 2026
General and administrative expense was $8.4 million in the three months ended September 30, 2026, compared to $8.8 million in the three months ended September 30, 2025, a decrease of $0.4 million, or 4%. This decrease was primarily due to a decrease of $1.4 million in non-cash stock-based compensation expense due to lower grant-date fair values of equity awards and a decrease of $0.1 million of public company costs related to the Reverse Split offset by an increase of $0.3 million in other personnel-related costs, and an increase of $0.5 million in professional fees, including $0.2 million in non-recurring litigation costs, an increase of $0.2 million in board of director fees, and an increase of $0.1 million in software costs reflecting our investment in AI-enabled tools to support operational efficiency.
For the Nine Months Ended September 30, 2026
General and administrative expense was $26.0 million in the nine months ended September 30, 2026, compared to $30.6 million in the nine months ended September 30, 2025, a decrease of $4.6 million, or 15%. This decrease was due to declines of $5.6 million in personnel-related costs due to decreased headcount, $0.2 million in infrastructure costs, and a $0.3 million decrease related to our divested product lines. These decreases were offset by the effects of $0.9 million in TSA fees related to divestitures received in 2025 with no such fees received in 2026, an increase of $0.3 million in board of director fees, and an increase of $0.3 million in legal fees.
Depreciation and Amortization Expense
| Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||||||||||||||||||||||||
| 2026 | 2025 | % Change | 2026 | 2025 | % Change | |||||||||||||||||||||||||||||||||
| (dollars in thousands) | ||||||||||||||||||||||||||||||||||||||
| Depreciation and amortization: | ||||||||||||||||||||||||||||||||||||||
| Depreciation | $ | 170 | $ | 217 | (22) | % | $ | 586 | $ | 740 | (21) | % | ||||||||||||||||||||||||||
| Amortization | 5,348 | 6,140 | (13) | % | 16,142 | 20,476 | (21) | % | ||||||||||||||||||||||||||||||
| Total depreciation and amortization | $ | 5,518 | $ | 6,357 | (13) | % | $ | 16,728 | $ | 21,216 | (21) | % | ||||||||||||||||||||||||||
For the Three Months Ended September 30, 2026
Depreciation and amortization expense was $5.5 million in the three months ended September 30, 2026, compared to $6.4 million in the three months ended September 30, 2025, a decrease of $0.9 million, or 13%. The decrease was primarily driven by lower amortization expense of $0.7 million related to intangible assets associated with Sunset Assets and $0.2 million decline related to intangible assets and depreciation associated with our core product line.
For the Nine Months Ended September 30, 2026
Depreciation and amortization expense was $16.7 million in the nine months ended September 30, 2026, compared to $21.2 million in the nine months ended September 30, 2025, a decrease of $4.5 million, or 21%. The decrease was primarily driven by lower amortization expense of $2.2 million related to intangible assets associated with the divested product lines and $2.0 million related to our Sunset Assets. The remaining decrease of $0.3 million related to intangible assets and depreciation of our core product lines.
26
Divestiture-related Expenses
| Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||||||||||||||||||||||||
| 2026 | 2025 | % Change | 2026 | 2025 | % Change | |||||||||||||||||||||||||||||||||
| (dollars in thousands) | ||||||||||||||||||||||||||||||||||||||
| Divestiture-related expenses | $ | — | $ | 778 | (100) | % | $ | 22 | $ | 9,402 | (100) | % | ||||||||||||||||||||||||||
For the Three Months Ended September 30, 2026
Divestiture-related expenses were nil in the three months ended September 30, 2026, compared to $0.8 million in the three months ended September 30, 2025. In conjunction with the divestitures completed in the first half of 2025, we incurred $0.3 million in fees related to a legacy vendor contract for out-sourced research and development that was terminated in 2025. Also, the divestiture-related expenses incurred in the three months ended September 30, 2025 consisted of $0.2 million in professional services fees and $0.3 million in outsourced data center costs related to the divestitures completed in the three months ended September 30, 2025. No divestiture-related expenses were incurred in the three months ended September 30, 2026 as no divestitures have been executed in 2026.
For the Nine Months Ended September 30, 2026
Divestiture-related expenses were nominal in the nine months ended September 30, 2026, compared to $9.4 million in the nine months ended September 30, 2025. In conjunction with the divestitures completed in the first half of 2025, we incurred $5.5 million in fees related to a legacy vendor contract for out-sourced research and development that was terminated in 2025. Also, the divestiture-related expenses incurred in the nine months ended September 30, 2025 consisted of $2.6 million in professional services fees, $0.8 million in severance costs, and $0.5 million in outsourced data center costs related to the divestitures completed in the nine months ended September 30, 2025. Limited divestiture-related expenses were incurred in the nine months ended September 30, 2026 as final expenses were incurred related to the 2025 divestitures and no divestitures have been executed in 2026.
Impairment of goodwill and other intangibles
| Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||||||||||||||||||||||||
| 2026 | 2025 | % Change | 2026 | 2025 | % Change | |||||||||||||||||||||||||||||||||
| (dollars in thousands) | ||||||||||||||||||||||||||||||||||||||
| Impairment of goodwill and other intangibles | $ | — | $ | — | — | % | $ | 35,246 | $ | 2,469 | 1,328 | % | ||||||||||||||||||||||||||
Goodwill impairment is recognized on a non-recurring basis when the carrying value (or GAAP basis book value) of our Company (which is our only reporting unit) exceeds the estimated fair value of our Company as determined by reference to a number of factors and assumptions. We assess goodwill for impairment annually on October 1st, or more frequently when an event occurs which could cause the carrying value of our Company to exceed the estimated fair value of our Company. During the three months ended June 30, 2026, we identified indicators of impairment. We performed a goodwill impairment evaluation which resulted in a goodwill impairment charge of $35.2 million in the nine months ended September 30, 2026. During the three months ended June 30, 2025, we identified a triggering event related to certain identifiable intangible assets related to Sunset Assets and performed a valuation of those long-lived assets. As a result of the valuation, we recorded $2.5 million of impairment expense related to certain identifiable intangible assets associated with Sunset Assets.
We periodically review the estimated useful lives of our identifiable intangible assets, taking into consideration any events or circumstances that might result in either a diminished fair value or revised useful life. During the three months ended September 30, 2026 and September 30, 2025, there were no impairments of identifiable intangible assets. We will continue to evaluate goodwill for impairment and future impairments of goodwill could occur if we experience significant stock price declines or other indicators of impairment.
27
Other Expense
| Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||||||||||||||||||||||||
| 2026 | 2025 | % Change | 2026 | 2025 | % Change | |||||||||||||||||||||||||||||||||
| (dollars in thousands) | ||||||||||||||||||||||||||||||||||||||
| Other expense: | ||||||||||||||||||||||||||||||||||||||
| Interest expense, net | $ | (5,083) | $ | (4,204) | 21 | % | $ | (14,068) | $ | (10,783) | 30 | % | ||||||||||||||||||||||||||
| Loss on divestitures of businesses | — | (473) | 100 | % | — | (24,364) | 100 | % | ||||||||||||||||||||||||||||||
| Loss on debt extinguishment | — | (2,301) | 100 | % | — | (2,301) | 100 | % | ||||||||||||||||||||||||||||||
| Other income (expense), net | 154 | 249 | (38) | % | (937) | (1,587) | (41) | % | ||||||||||||||||||||||||||||||
| Total other expense | $ | (4,929) | $ | (6,729) | (27) | % | $ | (15,005) | $ | (39,035) | (62) | % | ||||||||||||||||||||||||||
For the Three Months Ended September 30, 2026
Interest expense, net was $5.1 million in the three months ended September 30, 2026 compared to $4.2 million in the three months ended September 30, 2025, an increase of $0.9 million in net interest expense. This was due in part to the amortization effects of our interest rate derivatives which resulted in a $1.3 million year over year increase in non-cash interest expense recognized. The effects of the interest rate derivatives was offset by a decrease of $0.4 million in cash interest expense on our outstanding debt, driven by a lower debt balance in 2026 and offset by higher effective interest rates during the quarter.
No divestitures occurred in the three months ended September 30, 2026. In the three months ended September 30, 2025, we finalized the divestitures of certain product lines in order to focus on our higher margin and higher growth potential product lines.
Other income (expense), net recognized during the three months ended September 30, 2026 and 2025 was related primarily to foreign currency exchange fluctuations.
For the Nine Months Ended September 30, 2026
Interest expense, net was $14.1 million in the nine months ended September 30, 2026, compared to $10.8 million in the nine months ended September 30, 2025, an increase in net interest expense of $3.3 million, or 30%. The increase in interest expense is primarily attributable to the effects of our interest rate derivatives which reduced interest expense, net by $3.0 million in the nine months ended September 30, 2026 and decreased interest expense by $6.8 million in the nine months ended September 30, 2025, an increase in net non-cash interest expense of $3.8 million. This was offset by a $0.5 million reduction in interest expense related to the amortization of deferred financing costs.
Loss on divestitures of businesses was nil for the nine months ended September 30, 2026 as compared to $24.4 million in the nine months ended September 30, 2025. During the nine months ended September 30, 2025, we divested multiple product lines in order to focus on our higher margin and higher growth potential product lines. No such divestitures occurred in the nine months ended September 30, 2026.
Other expense, net was $0.9 million in the nine months ended September 30, 2026, compared to other expense, net of $1.6 million in the nine months ended September 30, 2025. Other income (expense), net recognized in the nine months ended September 30, 2026 and September 30, 2025 related primarily to foreign currency exchange fluctuations.
28
Benefit from (Provision for) Income Taxes
| Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||||||||||||||||||||||||
| 2026 | 2025 | % Change | 2026 | 2025 | % Change | |||||||||||||||||||||||||||||||||
| (dollars in thousands) | ||||||||||||||||||||||||||||||||||||||
| Benefit from (provision for) income taxes | $ | (855) | $ | 259 | (430) | % | $ | (2,682) | $ | 1,775 | (251) | % | ||||||||||||||||||||||||||
For the Three Months Ended September 30, 2026
The provision for income taxes was $0.9 million in the three months ended September 30, 2026, compared to a benefit from income taxes of $0.3 million in the three months ended September 30, 2025, resulting in an additional expense from income taxes of $1.2 million. The provision for income taxes for the three months ended September 30, 2026 relates primarily to income tax from non-U.S. operations. The benefit from income taxes in the three months ended September 30, 2025 relates primarily to the deferred tax benefit from the business divestitures in the third quarter and the impact of U.S. tax legislation, the One Big Beautiful Bill Act, passed in July 2025. This tax benefit is partially offset by the income tax from non-U.S. and U.S. operations.
For the Nine Months Ended September 30, 2026
The provision for income taxes was $2.7 million in the nine months ended September 30, 2026, compared to a benefit from income taxes of $1.8 million in the nine months ended September 30, 2025, an increase of expense of $4.5 million. This increase was primarily due to the deferred tax benefit from the business divestitures in the nine months ended September 30, 2025 and the impact of U.S. tax legislation, the One Big Beautiful Bill Act passed in July 2025.
Liquidity and Capital Resources
We finance our operations primarily through cash generated from operating activities and borrowings under credit facilities.
As of September 30, 2026, we had $29.5 million of cash, cash equivalents and restricted cash and $225.4 million of debt outstanding under our Credit Agreement. As of December 31, 2025, we had $30.0 million of cash, cash equivalents and restricted cash and $238.5 million of borrowings outstanding under our Term Loan. During the nine months ended September 30, 2026, we generated $13.7 million in cash from operations which funded $13.1 million in debt repayments.
Our cash and cash equivalents held by our foreign subsidiaries was $16.0 million as of September 30, 2026 and $10.0 million as of December 31, 2025. Our intent is to either permanently reinvest these funds outside the U.S. or use these funds to repay certain long-term intercompany loans. We do not provide for federal income taxes on the undistributed earnings of our foreign subsidiaries.
We believe our available cash and cash equivalents, together with our positive cash flows from operations and the liquidity provided by our $30 million revolving credit facility will be sufficient to meet our anticipated cash needs.
The following table summarizes our cash flows for the periods indicated:
| Nine Months Ended September 30, | |||||||||||
| 2026 | 2025 | ||||||||||
| (dollars in thousands) | |||||||||||
| Consolidated Statements of Cash Flows data: | |||||||||||
| Net cash provided by operating activities | $ | 13,735 | $ | 18,482 | |||||||
| Net cash provided by investing activities | 275 | 7,965 | |||||||||
| Net cash used in financing activities | (13,866) | (61,589) | |||||||||
| Effect of exchange rate fluctuations on cash, cash equivalents and restricted cash | (629) | 1,471 | |||||||||
| Change in cash, cash equivalents and restricted cash | (485) | (33,671) | |||||||||
| Cash, cash equivalents and restricted cash, beginning of period | 30,024 | 57,052 | |||||||||
| Cash, cash equivalents and restricted cash, end of period | $ | 29,539 | $ | 23,381 | |||||||
Cash Flows from Operating Activities
Cash provided by operating activities is significantly influenced by the amount of cash we invest in personnel and infrastructure to support the growth of our business. Our working capital consists primarily of cash, receivables from customers, prepaid assets, unbilled professional services, deferred commissions, accounts payable, accrued compensation and other accrued expenses, lease liabilities, and deferred revenues. The volume of professional services rendered, the volume and timing of customer bookings and
29
contract renewals, and the related timing of collections on those bookings and renewals, as well as the timing of spending commitments and payments of our accounts payable, accrued expenses, accrued payroll and related benefits, all affect these account balances.
Cash provided by operating activities was $13.7 million for the nine months ended September 30, 2026 compared to cash provided by operating activities of $18.5 million for the nine months ended September 30, 2025, a decrease of approximately $4.7 million. This decrease was primarily due to the non-recurring cash gains from the sales of our interest rate swaps in the nine months ended September 30, 2025 for $6.6 million. Other changes result from normal fluctuations in working capital and foreign currency exchange rates.
A substantial source of cash is invoicing for subscriptions and support fees in advance, which is recorded as deferred revenue, and is included on our condensed consolidated balance sheets as a liability. Deferred revenue consists of the unearned portion of booked fees for our software subscriptions and support, which is amortized into revenue in accordance with our revenue recognition policy. We assess our liquidity, in part, through an analysis of new subscriptions invoiced, expected cash receipts on new and existing subscriptions, and our ongoing operating expense requirements.
Cash Flows from Investing Activities
Historically, our investing activities have consisted of routine purchases of office equipment. Other activities, such as divestitures of businesses including the collections on note receivable from divested product lines, and purchases of other fixed assets, may affect our cash flows from investing activities in such periods as these transactions occur.
Cash provided by investing activities was $0.3 million for the nine months ended September 30, 2026 compared to cash provided by investing activities of $8.0 million for the nine months ended September 30, 2025, a decrease of $7.7 million. Cash activity consisted of $0.6 million in collections on the note receivable related to divestitures and $0.3 million in purchases of leasehold improvements and equipment for the nine months ended September 30, 2026 compared to cash proceeds from divestitures of businesses of $9.1 million, $1.3 million in purchases of leasehold improvements and equipment and $0.2 million in collections on the note receivable related to divestitures for the nine months ended September 30, 2025.
Cash Flows from Financing Activities
Historically, our primary financing activities have consisted of capital raises, proceeds from debt obligations, repayments and servicing of our debt obligations, share repurchases and share based employee payroll tax payment activity.
Cash used in financing activities was $13.9 million for the nine months ended September 30, 2026 compared to $61.6 million for the nine months ended September 30, 2025, a decrease of $47.7 million of cash used reflecting our continued deleveraging of the Company with $13.1 million in payments on our outstanding debt in the nine months ended September 30, 2026 as compared to a net cash outflow of $59.1 million in net debt payments made in the nine months ended September 30, 2025.
Critical Accounting Policies and the Use of Estimates
We prepare our condensed consolidated financial statements in accordance with generally accepted accounting principles in the United States (“GAAP”). The preparation of our condensed consolidated financial statements also requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, costs and expenses and related disclosures. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances. Actual results could differ significantly from the estimates made by our management. To the extent that there are differences between our estimates and actual results, our future financial statement presentation, financial condition, results of operations and cash flows will be affected. We believe that the accounting policy discussed below is critical to understanding our historical and future performance, as this policy relates to a more significant area involving management’s judgments and estimates.
Goodwill Impairment
We assess goodwill for impairment annually on October 1st, or more frequently when an event occurs which could cause the carrying value of the Company to exceed the estimated fair value of the Company.
As we operate as one reporting unit, the goodwill impairment evaluation is performed at the consolidated entity level by comparing the estimated fair value of the Company to its carrying value. We first assess qualitative factors to determine whether it is more likely than not that the fair value of our single reporting unit is less than its carrying value. Qualitative factors considered include: industry and market considerations; macroeconomic conditions; and other relevant events and factors. Based on the qualitative assessment, if it is determined that it is more likely than not that the Company's fair value is less than its carrying value, then we perform a quantitative analysis using a fair-value-based approach to determine if the fair value of our reporting unit is less than its carrying value. Performing a quantitative goodwill impairment test includes the determination of the fair value of a reporting unit and involves significant estimates and assumptions. These estimates and assumptions include, among others, revenue growth rates and operating margins used to calculate projected future cash flows, weighted average cost of capital, and future economic and market conditions. See Note 4. Goodwill and Other Intangible Assets for more information.
30
We are not aware of any specific event or circumstance that would require updates to our estimates or judgments or require us to revise the carrying value of our assets or liabilities as of November 4, 2026, the date of issuance of this Quarterly Report on Form 10-Q. Estimates may change as new events occur and additional information is obtained. Actual results could differ materially from these estimates under different assumptions or conditions.
Other Key Accounting Policies
Our unaudited interim financial statements and other financial information for the three and nine months ended September 30, 2026, as presented herein and in “Item 1. Financial Statements” to this Quarterly Report on Form 10-Q, reflect no material changes in our critical accounting policies and estimates as set forth in our Annual Report on Form 10-K for the year ended December 31, 2025 (the “Annual Report”). Please refer to our Annual Report for a detailed description of our critical accounting policies that involve significant management judgment.
We evaluate our estimates, judgments and assumptions on an ongoing basis, and while we believe that our estimates, judgments and assumptions are reasonable, they are based upon information available at the time. Actual results may differ significantly from these estimates under different assumptions, judgments or conditions.
Recent Accounting Pronouncements
For information with respect to recent accounting pronouncements and the impact of these pronouncements on our condensed consolidated financial statements, refer to “Note 2. Basis of Presentation and Summary of Significant Accounting Policies—Recent Accounting Pronouncements” to our condensed consolidated financial statements.
Item 3. Quantitative and Qualitative Disclosures About Market Risk
As a "smaller reporting company" as defined by Item 10 of Regulation S-K, the Company is not required to provide the information required by this Item.
Item 4. Controls and Procedures
Evaluation of Disclosure Controls and Procedures
The term “disclosure controls and procedures,” as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act refers to controls and procedures that are designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that such information is accumulated and communicated to a company’s management, including its principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosure.
Our management, including our Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of our disclosure controls and procedures as of September 30, 2026, the end of the period covered by this Quarterly Report on Form 10-Q. Based upon such evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures were effective as of such date. Our management has concluded that the condensed consolidated financial statements included in this report fairly present, in all material respects, our financial condition, results of operations and cash flows for the periods presented in conformity with GAAP.
Changes in Internal Control over Financial Reporting
There were no changes to our internal control over financial reporting (as defined in Rules 13a- 15(f) and 15d- 15(f) of the Exchange Act) during the quarter ended September 30, 2026 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
31
PART II – OTHER INFORMATION
Item 1. Legal Proceedings
For discussion regarding our legal proceedings, if any, please refer to Note 8. Commitments and Contingencies in our unaudited condensed consolidated financial statements in this Quarterly Report on Form 10-Q.
Item 1A. Risk Factors
In addition to the other information set forth in this report, you should carefully consider the factors discussed in Part I, “Item 1A. Risk Factors” in our 2025 Annual Report on Form 10-K, which could materially affect our business, financial condition or future results. There have been no material changes during 2026 to the risk factors that were included in the Company's Annual Report on Form 10-K, other than as set forth below.
Our failure to meet the continued listing requirements of Nasdaq could result in a delisting of our common stock, which could negatively impact the market price and liquidity of our common stock and our ability to access the capital markets.
Our common stock is listed on the Nasdaq Global Market, or Nasdaq. In order to maintain this listing, we must satisfy the continued listing requirements and standards of Nasdaq, including a minimum closing bid price requirement for our common stock of $1.00 per share and that the market value of publicly held shares of our common stock is at least $15 million. On April 7, 2026, we received a notification letter from Nasdaq notifying us that, for the last 30 consecutive business days, the closing bid price for our common stock has been below the minimum $1.00 per share required for continued listing on Nasdaq pursuant to Nasdaq Listing Rule 5450(a)(1) (“Rule 5450(a)(1)”). As provided in the notification letter from Nasdaq, we had 180 calendar days to regain compliance with Rule 5450(a)(1) by maintaining a closing bid price of at least $1.00 per share for a minimum of 10 consecutive trading days, subject to Nasdaq’s discretion. To regain compliance with Rule 5450(a)(1), we effected the Reverse Stock Split. On July 8, 2026, we received notification from Nasdaq that we had regained compliance with the minimum closing bid price requirement and, as a result, the matter of our noncompliance had been closed.
On July 31, 2026, we received a notification letter from Nasdaq notifying us that we no longer meet Nasdaq’s $15 million minimum market value of publicly held shares requirement under Nasdaq Listing Rule 5450(b)(2&3)(C) (the “MVPHS Requirement”) based on Nasdaq’s review of the market value of the Company’s publicly held shares for the previous 30 consecutive business days. The notification has no immediate effect on our listing or trading on the Nasdaq Global Market.
Nasdaq has provided us a period of 180 calendar days to regain compliance with the MVPHS Requirement, or until January 27, 2027 (the “Compliance Date”). If, at any time before the Compliance Date, our market value of publicly held shares closes at $15 million or more for a minimum of ten consecutive business days, but generally no more than 20 consecutive business days, Nasdaq will provide written notification to us that we have regained compliance with the MVPHS Requirement.
We intend to actively monitor the market value of our publicly held shares. We may evaluate and consider available options for regaining compliance with the MVPHS Requirement, as well as applying for a transfer to The Nasdaq Capital Market. However, there can be no assurance that we will take any specific action or be able to regain compliance with the MVPHS Requirement or otherwise maintain compliance with Nasdaq listing rules.
If we are unable to regain compliance by the Compliance Date, including any available extension, our common stock would be subject to delisting from Nasdaq. Further, even if we regain compliance, we may not be able to sustain compliance with the MVPHS Requirement in the long term or with the additional continued listing requirements and standards of Nasdaq. A delisting could significantly reduce the liquidity and market price of our common stock, limit investors’ ability to buy and sell our common stock, reduce analyst coverage, and negatively affect our ability to access the capital markets or complete strategic transactions on favorable terms, or at all. Delisting could also trigger certain contractual provisions or investor concerns that may further adversely affect us.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
Issuer Purchases of Equity Securities
On August 15, 2025, the Board of Directors authorized a stock repurchase program (the “2025 Share Repurchase Plan” as defined in Note 10. Stockholders' Deficit) in the aggregate amount of up to $10,000,000 (inclusive of any taxes payable as a result of such repurchase). The authorization does not have a specified expiration date. Accordingly, unless terminated earlier by resolution of the Board, the 2025 Share Repurchase Plan will expire when the Company has repurchased all shares authorized for repurchase thereunder. The Company is not obligated to acquire any particular amount of Common Stock and may modify or suspend the repurchases at any time in the Company’s discretion.
32
The following table provides information about purchases of equity securities that are registered by the Company pursuant to Section 12 of the Exchange Act during the three months ended September 30, 2026.
| Period | Total number of shares purchased | Average price paid per share (1) | Total number of shares purchased as part of the publicly announced plan | Maximum approximate dollar value of shares that may yet be purchased under the plan | ||||||||||||||||||||||
| 7/1/2026 -7/31/2026 | — | — | — | — | ||||||||||||||||||||||
| 8/1/2026 - 8/31/2026 | — | — | — | — | ||||||||||||||||||||||
| 9/1/2026 - 9/30/2026 | (2) | 106,229 | $3.59 | 98,009 | $ | 9,508,194 | ||||||||||||||||||||
| 106,229 | 98,009 | |||||||||||||||||||||||||
(1) Average price paid per share excludes commission costs and excise taxes associated with the above mentioned repurchases.
(2) The total number of shares repurchased includes 8,220 shares withheld from employees to satisfy the statutory withholding tax liability upon the vesting of share-based awards.
As of September 30, 2026, $9.5 million was still available for share repurchases under the 2025 Share Repurchase Plan.
Item 5. Other Information
Rule 10b5-1 Trading Plans
During the three months ended September 30, 2026, none of our officers (as defined in Rule 16a-1(f)) or directors adopted or terminated any Rule 10b5-1 trading arrangement or non-Rule 10b5-1 trading arrangement (as such terms are defined in Item 408 of Regulation S-K under the Securities Act).
Item 6. Exhibits
See the Exhibit Index immediately following this page, which is incorporated herein by reference.
33
EXHIBIT INDEX
| Exhibit Number | Exhibit Description | |||||||
| 101* | Inline XBRL (Extensible Business Reporting Language). The following materials from this Quarterly Report on Form 10-Q for the periods ended September 30, 2026, formatted in Inline XBRL: (i) condensed consolidated balance sheets of Upland Software, Inc., (ii) condensed consolidated statements of operations of Upland Software, Inc., (iii) condensed consolidated statements of comprehensive income (loss) of Upland Software, Inc., (iv) condensed consolidated statement of stockholders’ deficit of Upland Software, Inc., (v) condensed consolidated statements of cash flows of Upland Software, Inc. and (vi) notes to unaudited condensed consolidated financial statements of Upland Software, Inc. The instance document does not appear in the interactive data file because its XBRL tags are embedded within the Inline XBRL document. | |||||||
| 104* | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) | |||||||
* Filed herewith.
** Furnished herewith.
+ Certain personal information in this exhibit has been omitted in accordance with Regulation S-K Item 601(a)(6).
34
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| UPLAND SOFTWARE, INC. | |||||
| Dated: November 4, 2026 | /s/ Jennifer Simon | ||||
| Jennifer Simon | |||||
| Chief Financial Officer | |||||
35
UPLAND SOFTWARE, INC. EXECUTIVE EMPLOYMENT AGREEMENT
This Executive Employment Agreement (the “Agreement”) is entered into effective as of July 17, 2026 (the “Effective Date”) by and between Upland Software, Inc., a Delaware corporation (the “Company”), and Jennifer LaNell Simon (“Executive”).
RECITALS
WHEREAS, the Company and Executive desire to memorialize the terms of employment of Executive.
AGREEMENT
NOW, THEREFORE, in consideration of the premises and mutual covenants herein and for other good and valuable consideration, the parties agree as follows:
1.Duties and Scope of Employment.
(a)Positions and Duties. As of August 17th, 2026 (or, if the Company and Executive agree to a different employment commencement date, as of such employment commencement date), Executive will be employed by the Company as Chief Financial Officer of the Company. The period of Executive’s employment under this Agreement is referred to herein as the “Employment Term.” During the Employment Term, Executive will render such business and professional services in the performance of Executive’s duties as are customarily associated with Executive’s positions within the Company and Executive agrees to perform such other duties and functions as shall from time to time be reasonably assigned or delegated to Executive by the Company’s Chief Executive Officer.
(b)Obligations. During the Employment Term, Executive will perform Executive’s duties faithfully and to the best of Executive’s ability and will devote Executive’s full business efforts and time to the Company. During the Employment Term, Executive agrees to devote substantially all of her business time to the Company and shall not engage in any other material employment, occupation or consulting activity with material remuneration without the prior written consent of the Company’s Board of Directors (the “Board”).
2.At-Will Employment. Executive and the Company agree and acknowledge Executive’s employment with the Company constitutes “at-will” employment. Executive and the Company further agree and acknowledge that this employment relationship (and the Employment Term) may be terminated at any time, with or without cause or good reason, at the option of either Executive or the Company. Executive understands and agrees that neither Executive’s job performance nor promotions, commendations, bonuses or the like from the Company give rise to or in any way serve as the basis for modification, amendment, or extension, by implication or otherwise, of Executive’s employment with the Company.
3.Compensation.
(a)Base Salary. During the Employment Term, the Company will pay Executive as
compensation for Executive’s services a base salary at the annualized rate of $350,000 (the “Base Salary”). The Base Salary will be paid in regular installments in accordance with the Company’s normal payroll practices (subject to required withholding). During the Employment Term, Executive’s compensation shall be reviewed by the Board from time to time and at least once every 12 months. Any increase or decrease in Base Salary (together with the then existing Base Salary) shall serve as the “Base Salary” under this Agreement. The first and last payment will be adjusted, if necessary, to reflect a commencement or termination date other than the first or last working day of a pay period.
(b)Bonus. During Executive’s employment, Executive will be eligible to receive an annual bonus targeted at 75% of Executive’s Base Salary (prorated for Executive’s time in service to the Company for FY2026), less applicable withholdings, upon achievement of performance objectives to be determined by the Board or the Compensation Committee of the Board in its sole discretion, which may be based upon, among other things, achievement of revenue, acquisition and EBITDA targets. Any annual bonus will be earned only if the Company achieves the annual performance objectives during the designated time period, and, except as provided in Section 6(b) below, Executive is continuously employed by the Company through and including the day the bonus is paid. The Company shall pay such annual bonus at the same time as bonuses are normally paid to senior management, unless the Board approves an exception for payment of a particular bonus on a case by case basis, but in any event, any earned annual bonus shall be paid no later than March 31st of the year following the fiscal year in which such annual bonus was earned. Executive’s fiscal year 2026 bonus will be no less than $30,000 provided the Executive is continuously employed by the Company through and including the payment date.
(c)Equity Awards. Subject to approval by the Board or the Compensation Committee of the Board, Executive will be granted (i) Restricted Stock Units (“RSUs”) relating to 30,000 of the Company’s common shares, which, subject to Executive’s continued service with the Company (except as provided in Section 6(b) below), will vest quarterly with respect to 1/12th of the full RSU award beginning on a vesting commencement date no greater than 3 months from the Effective Date and subsequent quarterly vesting on the 16th of the 3-month anniversary of the first vesting date, with any fractional RSUs rolling over into the next quarter, and (ii) Performance-Based Restricted Stock Units (“PRSUs”), which, subject to Executive’s continued service with the Company and achievement of applicable performance goals (in each case, except as provided in Section 6(b) below), will vest with respect to 6,666 PRSUs upon achievement of “target” performance and 25,000 PRSUs upon achievement of “maximum” performance. The Performance metrics and goals applicable to the PRSUs will be determined by the Board or the Compensation Committee and reflected in Executive’s PRSU award agreement; provided, that, upon a Change in Control (as that term is defined in the Company’s 2024 Omnibus Incentive Plan (the “Plan”), a “Change in Control”), if the Change in Control occurs (a) on or before the first anniversary of the grant date, all then unvested PRSUs will vest immediately prior to the Change in Control at the maximum level, and (b) after the first anniversary of the grant date, all then unvested PRSUs will vest immediately prior to the Change in Control based on the actual level of achievement against the performance goals measured through the Change in Control (based on the per-share consideration payable in the Change in Control, to the extent the performance goals relate to stock price) rather than being measured through the last day of the performance period. The RSUs and PRSUs shall be governed in all respects by the terms of the Plan, and RSU and PRSU award agreements between Executive and
the Company, with the form of such award agreements being materially consistent with the forms of award agreements most recently
used by the Company for executive equity awards, subject to any modifications needed to reflect the vesting terms described above. Executive will be eligible for future annual grants of additional equity awards pursuant to the process applicable to other members of the executive leadership team, with the terms of any such grants to be determined in the sole discretion of the Board or the Compensation Committee of the Board.
(d)Employee Benefits. During the Employment Term, Executive will be entitled to participate in the employee benefit plans currently and hereafter maintained by the Company of general applicability to other senior executives of the Company. The Company reserves the right to cancel or change the benefit plans and programs it offers to its employees at any time.
4.Vacation. Executive will be entitled to paid vacation generally applicable to the senior executives of the Company, in accordance with the Company’s vacation policy.
5.Business Expenses. During the Employment Term, the Company will reimburse Executive for reasonable travel, entertainment and other expenses incurred by Executive in the furtherance of or in connection with the performance of Executive’s duties hereunder, in accordance with the Company’s expense reimbursement policy as in effect from time to time (the “Expense Reimbursement”).
6.Severance.
(a)For Cause Termination by the Company; Voluntary Termination without Good Reason by Executive. The Company may terminate Executive for Cause immediately by giving Executive written notice. Executive can terminate Executive’s employment at any time without Good Reason by giving the Company 60 days’ advance written notice. If the Company terminates Executive’s employment for Cause or if Executive terminates Executive’s employment without Good Reason, then Executive will: (i) receive the earned but unpaid Base Salary; (ii) any unreimbursed Expense Reimbursement (6(a)(i)-(ii) are the “Accrued Obligations”); and (iii) not receive any other compensation or benefits from the Company except as may be required by law or in accordance with established Company plans and policies; provided, however, nothing herein shall be deemed to alter or affect Executive’s vested rights in any 401(k) or other benefit plan with the Company, if any. Executive will be paid all of the Accrued Obligations on the Company’s first payroll date after Executive’s date of termination from employment or earlier if required by applicable law.
(b)Termination Without Cause by the Company; Termination For Good Reason by Executive. The Company can terminate Executive’s employment without Cause at any time by giving Executive written notice. Executive may resign Executive’s employment for Good Reason by following the procedures in the Good Reason definition below. If the Company terminates Executive’s employment without Cause or if Executive terminates Executive’s employment for Good Reason, then, subject to Executive’s compliance with all requirements in Section 6(d), (i) Executive shall be entitled to receive severance in the form of continuation of Executive’s Base Salary in effect on the effective date of termination for a period of twelve (12) months after the date of such termination to be paid periodically, following the Release Effective Date, in accordance with
the Company’s normal payroll practices; (ii) Executive will remain eligible to receive any annual bonus relating to the year preceding the year of termination that was earned, but, as of the termination date, had not yet been paid (payable at the same time such bonus would have been paid had employment not terminated),
(iii) (a) the portion of Executive’s then outstanding and unvested RSUs (and any other Company equity awards with vesting tied solely to continued service) that would have vested had Executive remained employed for twelve (12) months after the date of such termination shall vest as of the termination date (with any remaining portion forfeited) and (b) Executive’s PSUS (and any other Company equity awards with vesting tied to achievement of performance goals) shall remain outstanding and Executive will remain eligible to vest in a prorated portion of such awards, with such prorated portion equal to the product of (x) the number of PSUs (or other performance-based units) earned based on actual performance over the full performance period (or through the date of a Change in Control, if earlier), multiplied by (y) a fraction, the numerator of which is the number of days from and including the grant date through and including the date of termination and the denominator of which is the total number of days in the performance period (with any remaining portion forfeited); and (iv) if Executive timely elects continued coverage under COBRA for Executive or Executive’s covered dependents under the Company’s group health plans, the Company shall reimburse Executive for the employer-portion of the COBRA premiums, with the employer portion of such premiums being equal to the employer portion of the regular premiums the Company was paying for Executive (and Executive’s covered dependents, if applicable) health insurance coverage in effect for Executive (and Executive’s covered dependents, if applicable) on the termination date until the earliest of: (a) the twelve (12) month anniversary of the date of termination; (b) the date Executive commences new employment or self-employment that offers substantially equivalent health care coverage (and Executive agree to notify the Company of such other employment prior to the effective date thereof); or (c) the date Executive ceases to be eligible for COBRA continuation coverage for any reason. Notwithstanding the foregoing, upon Executive’s material breach of this Agreement or the Employee Proprietary Information Agreement entered into by the Company and Executive on or about the date hereof (the “EPIA”) the Company shall no longer be obligated to pay any amounts set forth in clauses 6(b)(i)-(iv), and Executive shall not be entitled to receive any further monthly installments of the severance payments and benefits set forth in clauses 6(b)(i)and (iv).
(c)Death or Disability. Upon termination of Executive’s employment for either death or Disability, Executive or Executive’s estate, as the case may be, shall be entitled to receive the Accrued Obligations, but Executive and Executive’s estate will not be eligible for any of the payments set forth in clauses 6(b)(i)-(iv). Further, subject to Executive’s compliance with all requirements in Section 6(d), any equity grants which are unvested at the time of the termination of Executive’s employment due to death or Disability shall automatically accelerate and become fully vested effective upon the date of such termination (with performance-based equity awards vesting at the target level). Upon termination of Executive’s employment due to death or Disability pursuant to this Section 6(c), Executive or Executive’s estate, as the case may be, shall have no further rights to any compensation or any other benefits under this Agreement except as explicitly provided herein. All other benefits, if any, due after Executive’s termination for death or Disability shall be determined in accordance with established Company plans and practices.
(d)Requirements for Severance. Executive (and Executive’s estate as the case may be) shall receive the payments in Section 6(b)(i)-(iv) and acceleration of any equity for death or
disability of this Agreement only if: (i) following the date of Executive’s termination of employment from the Company, Executive has signed and delivered to the Company a separation agreement containing a standard release of claims, in the form presented by and acceptable to the Board, which cannot be revoked in whole or part by such date (the date that the release can no longer be revoked is referred to as the “Release Effective Date”); and (ii) if Executive holds any other positions with the
Company or any affiliate, including a position on the Board, Executive will resign such position(s) to be effective no later than the date of Executive’s termination date (or such other date as requested by the Board); (iii) Executive returns all Company property; (iv) Executive complies with Executive’s post-termination obligations under this Agreement and the EPIA; and (v) Executive complies with the terms of the separation agreement.
(e)Section 409A.
(i)The Company intends that all payments made under this Agreement comply with, or are exempt from, the requirements of Section 409Aof the Internal Revenue Code of 1986, as amended, and any guidance promulgated thereunder (“Section 409A”) so that none of the payments or benefits will be subject to the additional tax imposed under Section 409A, and any ambiguities herein will be interpreted to so comply.
(ii)Executive and the Company agree to work together in good faith to consider amendments to this Agreement and to take such reasonable actions which are necessary, appropriate or desirable to avoid imposition of any additional tax or income recognition prior to actual payment to Executive under Section 409A. In no event will the Company reimburse Executive for any taxes that may be imposed on Executive as a result of Section 409A.
(iii)Notwithstanding anything to the contrary in this Agreement, to the extent (and only to the extent) required to avoid incurring taxes under Section 409A of the Internal Revenue Code of 1986, as amended (the “Code”) and the final regulations and any guidance promulgated thereunder (“Section 409A”), any severance payable to Executivepursuant to this Agreement payable within the first six (6) months following Executive’s termination of employment, will become payable on the first payroll date that occurs on or after the date six (6) months and one
(1) day following the date of Executive’s termination of employment (or, if earlier, the date of Executive’s death). All subsequent severance payments, if any, will be payable in accordance with the payment schedule applicable to each payment or benefit.
(iv)Any amount paid under the Agreement that satisfies the requirements of the “short-term deferral” rule set forth in Section 1.409A-1(b)(4) of the Treasury Regulations shall not constitute Deferred Compensation Separation Benefits for purposes of Section 6(c)(i) above.
(v)Any amount paid under the Agreement that qualifies as a payment made as a result of an involuntary separation from service pursuant to Section 1.409A-1(b)(9)(iii) of the Treasury Regulations that does not exceed the Section 409A Limit shall not constitute Deferred Compensation Separation Benefits for purposes of Section 6(e)(i) above. For purposes of this Section 6(e), “Section 409A Limit” will mean the lesser of two (2) times: (A) Executive’s annualized compensation based upon the annual rate of pay paid to Executive during the Company’s taxable year preceding the Company’s taxable year of Executive’s termination of employment as determined under Treasury Regulation 1.409A-1(b)(9)(iii)(A)(1) and any Internal Revenue Service guidance
issued with respect thereto; or (B) the maximum amount that may be taken into account under a qualified plan pursuant to Section 401(a)(17) of the Code for the year in which Executive’s employment is terminated.
(vi)Payments pursuant to this Agreement are intended to constitute separate payments for purposes of Treasury Regulation Section 1.409A-2(b)(2)(i) and payments of continued salary pursuant to Section 6(b) are intended to constitute a series of separate payments for purposes of Treasury Regulation Section 1.409A-2(b)(2)(iii).
(vii)Any reimbursements or in-kind benefits provided to or for Executive’s benefit that constitute deferred compensation for purposes of Section 409A shall be provided in a manner that complies with Treasury Regulation Section 1.409A-3(i)(1)(iv). Accordingly, (a) all such reimbursements will be made not later than the last day of the calendar year after the calendar year in which the expenses were incurred, (b) any right to such reimbursements or in-kind benefits will not be subject to liquidation or exchange for another benefit, and (c) the amount of the expenses eligible for reimbursement, or the amount of any in-kind benefit provided, during any taxable year will not affect the amount of expenses eligible for reimbursement, or the in-kind benefits provided, in any other taxable year.
7.Limitation on Payments. In the event that the severance and other benefits provided for in this Agreement or otherwise payable to Executive (i) constitute “parachute payments” within the meaning of Section 280G of the Code and (ii) but for this Section 7, would be subject to the excise tax imposed by Section 4999 of the Code, then Executive's severance and other benefits will be either: (i) delivered in full, or (ii) delivered as to such lesser extent which would result in no portion of such severance and other benefits being subject to excise tax under Section 4999 of the Code, whichever of the foregoing amounts, taking into account the applicable federal, state and local income taxes and the excise tax imposed by Section 4999, results in the receipt by Executive on an after-tax basis, of the greatest amount of severance and other benefits, notwithstanding that all or some portion of such severance and other benefits may be taxable under Section 4999 of the Code. Unless the Company and Executive otherwise agree in writing, any determination required under this Section 7 will be made in writing by the Company’s independent public accountants (or another firm specializing in Sections 280G and 4999 of the Code) (the “Accountants”), whose determination will be conclusive and binding upon Executive and the Company for all purposes. The Company shall select the Accountants prior to the date of the Change in Control. For purposes of making the calculations required by this Section 7, the Accountants may make reasonable assumptions and approximations concerning applicable taxes and may rely on reasonable, good faith interpretations concerning the application of Sections 280G and 4999 of the Code. The Company and Executive shall furnish to the Accountants such information and documents as the Accountants may reasonably request in order to make a determination under this Section 7. The Company shall bear all costs the Accountants may reasonably incur in connection with any calculations contemplated by this Section 7. In the event the Accountants determine that this Section 7 requires a reduction in Executive's severance or other benefits, unless determined otherwise by the Accountants, the reduction will occur in the following order (with the objective of reducing entitlements in a manner that minimizes the economic loss to Executive): (i) payments that are payable in cash that are valued at full value under Treasury Regulation Section 1.280G-1, Q&A 24(a) will be reduced (if necessary, to zero), with amounts that are payable last reduced first; (ii) payments and benefits due in respect of any equity valued at full value under Treasury Regulation Section 1.280G-1, Q&A 24(a), with the highest values reduced first (as such values are determined under Treasury Regulation Section
1.280G-1, Q&A 24) will next be reduced; (iii) payments that are payable in cash that are valued at less than full value under Treasury Regulation Section 1.280G-1, Q&A 24, with amounts that are payable last reduced first, will next be reduced; (iv) payments and benefits due in respect of any equity valued at less than full value under
Treasury Regulation Section 1.280G-1, Q&A 24, with the highest values reduced first (as such values are determined under Treasury Regulation Section 1.280G-1, Q&A 24) will next be reduced; and (v) all other non-cash benefits not otherwise described in clauses (ii) or (iv) will be next reduced pro-rata.
8.Definitions.
(a)Cause. For purposes of this Agreement, “Cause” means (i) Executive’s willful failure to perform the duties and obligations of Executive’s position with the Company; (ii) any material act of personal dishonesty, fraud or misrepresentation taken by Executive which was intended to result in substantial gain or personal enrichment of Executive at the expense of the Company;
(iii) Executive’s violation of a federal or state law or regulation applicable to the Company’s business which violation was or is reasonably likely to be materially injurious to the Company; (iv) Executive’s conviction of, or plea of nolo contendere or guilty to, a felony under the laws of the United States or any State, excluding felonies for minor traffic violation and vicarious liability (so long as Executive did not know of the felony and did not willfully violate the law); (v) Executive’s material breach of the terms of this Agreement or the EPIA; or (vi) Executive’s material violation of any written Company policy applicable to senior executives, including without limitation policies relating to harassment, discrimination, workplace conduct, ethics compliance. The Board may place Executive on paid leave for up to thirty (30) days while it is determining whether there is a basis to terminate Executive’s employment for Cause.
(b)Good Reason. For purposes of this Agreement, “Good Reason” means, (i) without Executive’s consent, a material reduction of Executive’s duties or responsibilities relative to Executive’s duties or responsibilities as in effect immediately prior to such reduction; provided, however, any reduction in Executive’s duties or responsibilities resulting solely from the Company being acquired by and made a part of a larger entity (as, for example, when a chief financial officer becomes an employee of the acquiring corporation following a Change in Control but is not the chief financial officer of the acquiring corporation) shall not constitute Good Reason; (ii) without Executive’s written consent, a material reduction in the Base Salary of Executive as in effect immediately prior to such reduction, unless such reduction is part of a reduction in expenses generally affecting senior executives of the Company; (iii) without Executive’s consent, a material reduction by the Company in the kind or level of employee benefits to which Executive was entitled immediately prior to such reduction, with the result that Executive’s overall benefits package is materially reduced, unless such reduction is part of a reduction in benefits generally affecting senior executives of the Company or (iv) without Executive’s consent, her relocation to a facility or a location more than twenty-five (25) miles from her present working locations (currently Austin, Texas). Good Reason shall not exist unless Executive provides (i) notice to the Company within ninety (90) days of the initial existence of the condition triggering Good Reason and (ii) the Company the opportunity of at least thirty (30) days to cure such condition. In order to resign employment for Good Reason, Executive must resign Executive’s employment within 30 days of the
Company’s failure to cure such condition, other Executive’s waives such condition as a basis for resigning for Good Reason.
(c)Disability. For purposes of this Agreement, “Disability” means Executive’s inability to perform Executive’s duties due to Executive’s physical or mental incapacity, as reasonably determined by the Board or its designee, for an aggregate of 180 days (whether consecutive or not) in any 365 consecutive day period, except as otherwise required by law.
9.Confidential Information. Executive confirms Executive’s obligations under EPIA.
10.Assignment. This Agreement will be binding upon and inure to the benefit of (a) the heirs, executors and legal representatives of Executive upon Executive’s death and (b) any successor of the Company. Any such successor of the Company will be deemed substituted for the Company under the terms of this Agreement for all purposes. For this purpose, “successor” means any person, firm, corporation or other business entity which at any time, whether by purchase, merger or otherwise, directly or indirectly acquires all or substantially all of the assets or business of the Company. None of the rights of Executive to receive any form of compensation payable pursuant to this Agreement may be assigned or transferred except by will or the laws of descent and distribution. None of the obligations of Executive under this Agreement may be assigned or transferred. Any other attempted assignment, transfer, conveyance or other disposition of Executive’s right to compensation or other benefits will be null and void.
11.Notices. All notices, requests, and other communications hereunder must be in writing and will be deemed to have been duly given only if (i) delivered personally or by overnight courier, (ii) delivered by facsimile transmission with delivery confirmation, or (iii) mailed (postage prepaid by certified or registered mail, return receipt requested) (effective three business days following mailing) to Executive at the address set forth on the first page hereof or to the Company at the Company’s then-current principal executive office. An electronic communication (“Electronic Notice”) shall be deemed written notice for purposes of this Agreement if sent with return receipt requested to the electronic mail address specified by the receiving party. Electronic Notice shall be deemed received at the time the party sending Electronic Notice receives verification of receipt by the receiving party. Any party receiving Electronic Notice may request and shall be entitled to receive the notice on paper, in a nonelectronic form (“Nonelectronic Notice”) which shall be sent to the requesting party within five (5) days after receipt of the written request for Nonelectronic Notice. Any party from time to time may change its address, facsimile number, electronic mail address, or other information for the purpose of notices to that party by giving written notice specifying such change to the other party hereto.
12.Severability. In the event that any provision of this Agreement becomes or is declared by a court of competent jurisdiction to be illegal, unenforceable or void, this Agreement will continue in full force and effect without said provision.
13.Arbitration. Executive acknowledges that, in connection with this Agreement, Executive is signing the EPIA, which contains a mutual agreement to arbitrate disputes. The parties expressly incorporate the EPIA by reference into this Agreement, including but not limited to the arbitration agreement set forth in Section 13 of the EPIA.
14.Term. The term of this Agreement shall commence on the Effective Date and continue until otherwise terminated by the parties pursuant to Section 6 above. Notwithstanding the foregoing, Sections 6 –19 of this Agreement shall survive any such termination or expiration.
15.Integration. This Agreement, the EPIA and the Indemnification Agreement between the Company and Executive, represents the entire agreement and understanding between the parties as to the subject matter herein and supersedes all prior or contemporaneous agreements whether written or oral. To the extent that any provision of the EPIA conflicts with a provision of this Agreement, this Agreement shall control. No waiver, alteration or modification of any of the provisions of this
Agreement will be binding unless in writing and signed by duly authorized representatives of the parties hereto.
16.No Waiver. Other than expressly set forth herein, nothing in this Agreement constitutes or shall be deemed to constitute a waiver of, or otherwise reduce, affect or impair, any of the rights or remedies available to Executive under any applicable law or at equity, all of such rights or remedies being hereby expressly reserved.
17.Tax Withholding. All payments made pursuant to this Agreement will be subject to withholding of applicable taxes.
18.Governing Law; Consent to Personal Jurisdiction. THIS AGREEMENT WILL BE GOVERNED BY THE LAWS OF THE STATE OF TEXAS WITHOUT REGARD FOR CONFLICTS OF LAWS PRINCIPLES. SUBJECT TO THE ARBITRATION PROVISION IN SECTION 133, EXECUTIVE HEREBY EXPRESSLY CONSENTS TO THE PERSONAL JURISDICTION OF THE STATE AND FEDERAL COURTS LOCATED IN TRAVIS COUNTY, TEXAS FOR ANY LAWSUIT FILED THERE AGAINST EXECUTIVE BY THE COMPANY CONCERNING EXECUTIVE’S EMPLOYMENT OR THE TERMINATION OF EXECUTIVE’S EMPLOYMENT OR ARISING FROM OR RELATING TO THIS AGREEMENT.
19.Acknowledgment. Executive acknowledges that Executive has had the opportunity to discuss this matter with and obtain advice from Executive’s private attorney, Executive has had sufficient time to, and has carefully read and fully understands all the provisions of this Agreement, and is knowingly and voluntarily entering into this Agreement.
[signature page follows]
IN WITNESS WHEREOF, each of the parties has executed this Agreement, in the case of the Company by their duly authorized officers, as of the day and year first above written.
“COMPANY”
Upland Software, Inc.
By:
Name:Sean Nathaniel
Title: Chief Executive Officer
“EXECUTIVE”

Jennifer LaNell Simon
Exhibit 31.1
CERTIFICATION PURSUANT TO RULES 13A-14(A) AND 15D-14(A) OF THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Sean Nathaniel, certify that:
1.I have reviewed this Quarterly Report on Form 10-Q of Upland Software, Inc.;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal controls over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c.Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d.Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
Date: November 4, 2026
| /s/ Sean Nathaniel | ||
| Sean Nathaniel | ||
| Chief Executive Officer | ||
| (Principal Executive Officer) | ||
Exhibit 31.2
CERTIFICATION PURSUANT TO RULES 13A-14(A) AND 15D-14(A) OF THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Jennifer Simon, certify that:
1.I have reviewed this Quarterly Report on Form 10-Q of Upland Software, Inc.;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal controls over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c.Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d.Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
Date: November 4, 2026
| /s/ Jennifer Simon | ||
| Jennifer Simon | ||
| Chief Financial Officer | ||
| (Principal Financial Officer) | ||
Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Upland Software, Inc. (the “Company”) on Form 10-Q for the quarter ended September 30, 2026 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Sean Nathaniel, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:
1. The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: November 4, 2026
| /s/ Sean Nathaniel | ||
| Sean Nathaniel | ||
| Chief Executive Officer | ||
Exhibit 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Upland Software, Inc. (the “Company”) on Form 10-Q for the quarter ended September 30, 2026 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Jennifer Simon, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:
1. The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: November 4, 2026
| /s/ Jennifer Simon | ||
| Jennifer Simon | ||
| Chief Financial Officer | ||